[
  {
    "bcr_patient_uuid": "9a50e7e4-831d-489f-87d2-979e987561cc",
    "patient_ID": "TCGA.05.4384",
    "bcr_drug_barcode": "TCGA-05-4384-D36331",
    "bcr_drug_uuid": "281E8624-371D-4473-BA5E-E41E0C21D551",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a50e7e4-831d-489f-87d2-979e987561cc",
    "patient_ID": "TCGA.05.4384",
    "bcr_drug_barcode": "TCGA-05-4384-D36332",
    "bcr_drug_uuid": "19860FED-A03B-407A-9081-F0CD43C3BD54",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a50e7e4-831d-489f-87d2-979e987561cc",
    "patient_ID": "TCGA.05.4384",
    "bcr_drug_barcode": "TCGA-05-4384-D36333",
    "bcr_drug_uuid": "8009725B-0627-43CB-B0EB-37B12CCB3848",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 395,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 426,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a50e7e4-831d-489f-87d2-979e987561cc",
    "patient_ID": "TCGA.05.4384",
    "bcr_drug_barcode": "TCGA-05-4384-D36334",
    "bcr_drug_uuid": "5B01A1B0-5946-4ECC-A816-E6DC557CF563",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 426,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b8475929-2d9d-4909-bd62-59684a140bd7",
    "patient_ID": "TCGA.05.4390",
    "bcr_drug_barcode": "TCGA-05-4390-D36457",
    "bcr_drug_uuid": "1C563458-F78C-43FA-9FD0-9F31F386B0D7",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b8475929-2d9d-4909-bd62-59684a140bd7",
    "patient_ID": "TCGA.05.4390",
    "bcr_drug_barcode": "TCGA-05-4390-D36458",
    "bcr_drug_uuid": "E9C5A69B-2C5F-40D1-9CE9-46F808524536",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31c96e35-5e2f-429c-b12a-7bc5a497a300",
    "patient_ID": "TCGA.05.4398",
    "bcr_drug_barcode": "TCGA-05-4398-D36463",
    "bcr_drug_uuid": "9DC1C815-EC00-4CDE-BB84-3F8EB3DD9B4F",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31c96e35-5e2f-429c-b12a-7bc5a497a300",
    "patient_ID": "TCGA.05.4398",
    "bcr_drug_barcode": "TCGA-05-4398-D36465",
    "bcr_drug_uuid": "48CF8515-16A9-4E33-B2F5-AC6157DC8C51",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722d6818-f1cb-49f4-b68a-fd0a31304681",
    "patient_ID": "TCGA.05.4402",
    "bcr_drug_barcode": "TCGA-05-4402-D36467",
    "bcr_drug_uuid": "C22C6B31-7A7B-4961-B95D-137666A2C3FF",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722d6818-f1cb-49f4-b68a-fd0a31304681",
    "patient_ID": "TCGA.05.4402",
    "bcr_drug_barcode": "TCGA-05-4402-D36468",
    "bcr_drug_uuid": "BA9F9930-88F2-4DA0-982D-BEDBEA793B76",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722d6818-f1cb-49f4-b68a-fd0a31304681",
    "patient_ID": "TCGA.05.4402",
    "bcr_drug_barcode": "TCGA-05-4402-D36469",
    "bcr_drug_uuid": "8CEA61DA-614E-4CE9-8202-877E85ECC83F",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66763a0c-6cda-4832-a0cc-e7b496d78eaa",
    "patient_ID": "TCGA.05.4424",
    "bcr_drug_barcode": "TCGA-05-4424-D36537",
    "bcr_drug_uuid": "65585949-E6ED-42E6-B1D5-002FBB849BB1",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69b23036-add9-42c9-941f-02fb74d9b08c",
    "patient_ID": "TCGA.05.4425",
    "bcr_drug_barcode": "TCGA-05-4425-D36541",
    "bcr_drug_uuid": "9F72525F-2709-42EF-831A-25435428F054",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69b23036-add9-42c9-941f-02fb74d9b08c",
    "patient_ID": "TCGA.05.4425",
    "bcr_drug_barcode": "TCGA-05-4425-D36542",
    "bcr_drug_uuid": "E3F50215-27BD-43FC-BD2F-C7C06D44035E",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78a24c56-576c-4245-bb42-6603b3d19897",
    "patient_ID": "TCGA.05.4427",
    "bcr_drug_barcode": "TCGA-05-4427-D36565",
    "bcr_drug_uuid": "8809622A-D398-4D9D-95B7-92480AD0CA12",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78a24c56-576c-4245-bb42-6603b3d19897",
    "patient_ID": "TCGA.05.4427",
    "bcr_drug_barcode": "TCGA-05-4427-D36566",
    "bcr_drug_uuid": "2978B988-DC8D-449A-83CC-6C4831AA0FE2",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e737f650-b72d-44e7-b750-558a56716803",
    "patient_ID": "TCGA.05.4432",
    "bcr_drug_barcode": "TCGA-05-4432-D36425",
    "bcr_drug_uuid": "50774761-63F6-4356-AFF1-6CB33BC143F8",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e737f650-b72d-44e7-b750-558a56716803",
    "patient_ID": "TCGA.05.4432",
    "bcr_drug_barcode": "TCGA-05-4432-D36426",
    "bcr_drug_uuid": "7CDBF312-289A-49AD-989C-52221C8B04E8",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9b4eeecb-6aff-435b-a244-ec362af92b7f",
    "patient_ID": "TCGA.05.5425",
    "bcr_drug_barcode": "TCGA-05-5425-D36415",
    "bcr_drug_uuid": "B19108E0-0562-45A5-A84F-1EB6D1A472B0",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 761,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9b4eeecb-6aff-435b-a244-ec362af92b7f",
    "patient_ID": "TCGA.05.5425",
    "bcr_drug_barcode": "TCGA-05-5425-D36417",
    "bcr_drug_uuid": "5BEC112E-BA69-4195-810A-A41A10693781",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 761,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9b4eeecb-6aff-435b-a244-ec362af92b7f",
    "patient_ID": "TCGA.05.5425",
    "bcr_drug_barcode": "TCGA-05-5425-D36418",
    "bcr_drug_uuid": "188127D6-E1B8-4C4D-907E-3CEEF9D3C816",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "GEFITINIB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 669,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9b4eeecb-6aff-435b-a244-ec362af92b7f",
    "patient_ID": "TCGA.05.5425",
    "bcr_drug_barcode": "TCGA-05-5425-D36419",
    "bcr_drug_uuid": "48588402-EA64-4934-989B-E4FAB2CEC262",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 792,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3fe8f8e4-5396-4362-82f5-366e2fb69db2",
    "patient_ID": "TCGA.05.5428",
    "bcr_drug_barcode": "TCGA-05-5428-D36413",
    "bcr_drug_uuid": "871796B4-AAF5-4244-9638-B330F655C4AF",
    "form_completion_date": "2012-10-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3fe8f8e4-5396-4362-82f5-366e2fb69db2",
    "patient_ID": "TCGA.05.5428",
    "bcr_drug_barcode": "TCGA-05-5428-D36412",
    "bcr_drug_uuid": "6CA3C122-D3BF-44D7-A79B-A496388F0C6E",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc4bd56a-25c5-4c48-b583-ac3aeb778ca6",
    "patient_ID": "TCGA.38.4628",
    "bcr_drug_barcode": "TCGA-38-4628-D4678",
    "bcr_drug_uuid": "0c5ddee7-c7b0-44a1-97d7-c6eb11c9b514",
    "form_completion_date": "2010-12-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1238,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cc4bd56a-25c5-4c48-b583-ac3aeb778ca6",
    "patient_ID": "TCGA.38.4628",
    "bcr_drug_barcode": "TCGA-38-4628-D13831",
    "bcr_drug_uuid": "357b5e2f-bb1b-41f7-8c7c-4ea6dd8a2fd3",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1238,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "875333ab-9048-462d-aaa2-693ad127e3cc",
    "patient_ID": "TCGA.38.4632",
    "bcr_drug_barcode": "TCGA-38-4632-D4844",
    "bcr_drug_uuid": "54475225-34f4-4948-996f-e97089cd5a04",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1169,
    "drug_cycles": 2,
    "drug_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "875333ab-9048-462d-aaa2-693ad127e3cc",
    "patient_ID": "TCGA.38.4632",
    "bcr_drug_barcode": "TCGA-38-4632-D4840",
    "bcr_drug_uuid": "77d7b5e2-ec9e-44d8-a8bb-fc29c602ae6a",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 679,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 802,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "875333ab-9048-462d-aaa2-693ad127e3cc",
    "patient_ID": "TCGA.38.4632",
    "bcr_drug_barcode": "TCGA-38-4632-D13824",
    "bcr_drug_uuid": "e8d4b552-6c8f-4cfb-93cd-267605c6a506",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1169,
    "drug_cycles": 2,
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "875333ab-9048-462d-aaa2-693ad127e3cc",
    "patient_ID": "TCGA.38.4632",
    "bcr_drug_barcode": "TCGA-38-4632-D13822",
    "bcr_drug_uuid": "d1a79d21-2ed8-415a-aea3-af762a661683",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 679,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 802,
    "drug_cycles": 6,
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "edf80622-aea2-4b50-bb69-691d6708aa83",
    "patient_ID": "TCGA.38.6178",
    "bcr_drug_barcode": "TCGA-38-6178-D22083",
    "bcr_drug_uuid": "5ad35ad6-ca82-4ca6-9db3-cd262b61c75f",
    "form_completion_date": "2012-2-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "edf80622-aea2-4b50-bb69-691d6708aa83",
    "patient_ID": "TCGA.38.6178",
    "bcr_drug_barcode": "TCGA-38-6178-D22081",
    "bcr_drug_uuid": "7068c8ff-4abb-437c-961f-cffe77e553b7",
    "form_completion_date": "2012-2-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8214a0d1-5e2d-4a7a-acb1-e5580755db83",
    "patient_ID": "TCGA.38.7271",
    "bcr_drug_barcode": "TCGA-38-7271-D18310",
    "bcr_drug_uuid": "fac1fe79-b59c-4d7b-b36a-89b3c8e29166",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 574,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 574,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 798
  },
  {
    "bcr_patient_uuid": "8214a0d1-5e2d-4a7a-acb1-e5580755db83",
    "patient_ID": "TCGA.38.7271",
    "bcr_drug_barcode": "TCGA-38-7271-D18306",
    "bcr_drug_uuid": "39b80d4f-cb2c-42f3-9e88-32dadd933c17",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 371,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 324
  },
  {
    "bcr_patient_uuid": "8214a0d1-5e2d-4a7a-acb1-e5580755db83",
    "patient_ID": "TCGA.38.7271",
    "bcr_drug_barcode": "TCGA-38-7271-D18311",
    "bcr_drug_uuid": "be281462-f8ee-4c19-95d2-3a8f7295265f",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 574,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 623,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 1760
  },
  {
    "bcr_patient_uuid": "bf15f7ad-9d92-473b-91d1-f24aa373ab97",
    "patient_ID": "TCGA.44.2659",
    "bcr_drug_barcode": "TCGA-44-2659-D5026",
    "bcr_drug_uuid": "cc1ab570-e73a-425d-9314-fcd5bcd1998e",
    "form_completion_date": "2010-10-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "bf15f7ad-9d92-473b-91d1-f24aa373ab97",
    "patient_ID": "TCGA.44.2659",
    "bcr_drug_barcode": "TCGA-44-2659-D5025",
    "bcr_drug_uuid": "110a7cbc-d353-458a-93f3-10c16adcb893",
    "form_completion_date": "2010-10-20",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "ccda26c1-a6d6-4317-8cf8-8a87e15ce12e",
    "patient_ID": "TCGA.44.2662",
    "bcr_drug_barcode": "TCGA-44-2662-D5034",
    "bcr_drug_uuid": "11737323-43bd-4c4f-9c44-43683d677c92",
    "form_completion_date": "2010-10-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 362,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 935,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3817
  },
  {
    "bcr_patient_uuid": "ccda26c1-a6d6-4317-8cf8-8a87e15ce12e",
    "patient_ID": "TCGA.44.2662",
    "bcr_drug_barcode": "TCGA-44-2662-D5033",
    "bcr_drug_uuid": "49760024-30c8-4540-a1fc-44ee2672a837",
    "form_completion_date": "2010-10-21",
    "pharmaceutical_therapy_drug_name": "REC MAGE 3-AS + AS15 ACS1 / PLACEBO VACCINE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 5,
    "pharma_type_other": "GSK MAGE VACCINE STUDY",
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "drug_dose": 0.5,
    "regimen_number": 1,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "ccda26c1-a6d6-4317-8cf8-8a87e15ce12e",
    "patient_ID": "TCGA.44.2662",
    "bcr_drug_barcode": "TCGA-44-2662-D5035",
    "bcr_drug_uuid": "ada4d1fb-41a4-4448-8509-1d01a0c093c1",
    "form_completion_date": "2010-10-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 362,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 480,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1608
  },
  {
    "bcr_patient_uuid": "fb79c491-7b01-42ae-8369-8364e442e31b",
    "patient_ID": "TCGA.44.2665",
    "bcr_drug_barcode": "TCGA-44-2665-D5300",
    "bcr_drug_uuid": "166a00a1-1d11-4315-85ec-f0ff6b2c184b",
    "form_completion_date": "2010-10-13",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1139,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12988
  },
  {
    "bcr_patient_uuid": "fb79c491-7b01-42ae-8369-8364e442e31b",
    "patient_ID": "TCGA.44.2665",
    "bcr_drug_barcode": "TCGA-44-2665-D5303",
    "bcr_drug_uuid": "180ce2c6-d1aa-416d-bcd6-2ecd63c5793d",
    "form_completion_date": "2010-10-13",
    "pharmaceutical_therapy_drug_name": "PEMETREXED DISODIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 910,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3625
  },
  {
    "bcr_patient_uuid": "fb79c491-7b01-42ae-8369-8364e442e31b",
    "patient_ID": "TCGA.44.2665",
    "bcr_drug_barcode": "TCGA-44-2665-D5301",
    "bcr_drug_uuid": "b9858076-20a0-4a78-b334-9965e070182e",
    "form_completion_date": "2010-10-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 137,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 545
  },
  {
    "bcr_patient_uuid": "3bd6badb-27ff-4d8d-b206-4d28dc264862",
    "patient_ID": "TCGA.44.3396",
    "bcr_drug_barcode": "TCGA-44-3396-D5019",
    "bcr_drug_uuid": "d9d59d53-accc-4e89-bc4c-c13fde7550f1",
    "form_completion_date": "2010-10-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "3bd6badb-27ff-4d8d-b206-4d28dc264862",
    "patient_ID": "TCGA.44.3396",
    "bcr_drug_barcode": "TCGA-44-3396-D5017",
    "bcr_drug_uuid": "cb7c2370-e79f-4706-9c22-02b0152ffc04",
    "form_completion_date": "2010-10-22",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 850,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "bcr_patient_uuid": "6e3b6b72-142d-4b8d-a462-28a205796e41",
    "patient_ID": "TCGA.44.3918",
    "bcr_drug_barcode": "TCGA-44-3918-D20986",
    "bcr_drug_uuid": "16f14090-dd3a-4b0c-91c7-998cee0e8d40",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 543,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 648,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3380
  },
  {
    "bcr_patient_uuid": "6e3b6b72-142d-4b8d-a462-28a205796e41",
    "patient_ID": "TCGA.44.3918",
    "bcr_drug_barcode": "TCGA-44-3918-D20985",
    "bcr_drug_uuid": "4cc469d8-02e3-4ef9-88d3-cd70b4fbc386",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 543,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 648,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 930,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5660
  },
  {
    "bcr_patient_uuid": "68b86559-38b2-41f2-b66e-c3c2b628b14d",
    "patient_ID": "TCGA.44.4112",
    "bcr_drug_barcode": "TCGA-44-4112-D13710",
    "bcr_drug_uuid": "75c42d72-040a-42d2-953d-8a4a9c467011",
    "form_completion_date": "2011-7-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 165,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "68b86559-38b2-41f2-b66e-c3c2b628b14d",
    "patient_ID": "TCGA.44.4112",
    "bcr_drug_barcode": "TCGA-44-4112-D13711",
    "bcr_drug_uuid": "1c60b058-9bc5-4159-996a-57177380956d",
    "form_completion_date": "2011-7-11",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "27fceec1-3298-4cdd-a4e6-8f5cf34604f0",
    "patient_ID": "TCGA.44.5643",
    "bcr_drug_barcode": "TCGA-44-5643-D12950",
    "bcr_drug_uuid": "9fedb69f-cc66-4f2f-b9f0-71e1dd2d695b",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 132,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 19800
  },
  {
    "bcr_patient_uuid": "27fceec1-3298-4cdd-a4e6-8f5cf34604f0",
    "patient_ID": "TCGA.44.5643",
    "bcr_drug_barcode": "TCGA-44-5643-D12954",
    "bcr_drug_uuid": "21d67e97-9cd3-4de6-8df9-83f9a1330403",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1505
  },
  {
    "bcr_patient_uuid": "27fceec1-3298-4cdd-a4e6-8f5cf34604f0",
    "patient_ID": "TCGA.44.5643",
    "bcr_drug_barcode": "TCGA-44-5643-D12952",
    "bcr_drug_uuid": "2b6a8199-4f87-4880-b81d-ac2b704b0451",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2035
  },
  {
    "bcr_patient_uuid": "0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5",
    "patient_ID": "TCGA.44.6146",
    "bcr_drug_barcode": "TCGA-44-6146-D12759",
    "bcr_drug_uuid": "e1605149-0bd0-4889-8db8-71f1eeacda90",
    "form_completion_date": "2011-6-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 44,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 165,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5",
    "patient_ID": "TCGA.44.6146",
    "bcr_drug_barcode": "TCGA-44-6146-D12761",
    "bcr_drug_uuid": "e3862c58-05db-4b2a-8c54-fc72bee3ce23",
    "form_completion_date": "2011-6-7",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5",
    "patient_ID": "TCGA.44.6146",
    "bcr_drug_barcode": "TCGA-44-6146-D12762",
    "bcr_drug_uuid": "b7252803-5a38-42ce-8246-c0298c823279",
    "form_completion_date": "2011-6-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "33c71ead-4c2a-476d-85ef-885dbbfc2cbd",
    "patient_ID": "TCGA.44.6774",
    "bcr_drug_barcode": "TCGA-44-6774-D30173",
    "bcr_drug_uuid": "DB768637-FE0C-46B2-8620-1FA1BE5C429A",
    "form_completion_date": "2012-4-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "33c71ead-4c2a-476d-85ef-885dbbfc2cbd",
    "patient_ID": "TCGA.44.6774",
    "bcr_drug_barcode": "TCGA-44-6774-D30170",
    "bcr_drug_uuid": "0AF8AD7E-12CE-4B54-A0AD-E385FCB7BFDF",
    "form_completion_date": "2012-4-3",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "33c71ead-4c2a-476d-85ef-885dbbfc2cbd",
    "patient_ID": "TCGA.44.6774",
    "bcr_drug_barcode": "TCGA-44-6774-D30176",
    "bcr_drug_uuid": "43806307-3701-4257-911D-EA7D9340D5DE",
    "form_completion_date": "2012-4-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1085
  },
  {
    "bcr_patient_uuid": "cbbea9f1-396a-4bf3-b67c-2cac3394dceb",
    "patient_ID": "TCGA.44.6779",
    "bcr_drug_barcode": "TCGA-44-6779-D16021",
    "bcr_drug_uuid": "4d765560-c992-4deb-be5c-3f95e52efc0a",
    "form_completion_date": "2011-9-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 650,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "cbbea9f1-396a-4bf3-b67c-2cac3394dceb",
    "patient_ID": "TCGA.44.6779",
    "bcr_drug_barcode": "TCGA-44-6779-D16023",
    "bcr_drug_uuid": "ea0269ad-e8e3-4fa6-a6fd-adc142fc13a0",
    "form_completion_date": "2011-9-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "cbbea9f1-396a-4bf3-b67c-2cac3394dceb",
    "patient_ID": "TCGA.44.6779",
    "bcr_drug_barcode": "TCGA-44-6779-D16019",
    "bcr_drug_uuid": "cf85260a-95a7-40dd-85dc-fe3146f7e584",
    "form_completion_date": "2011-9-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1360
  },
  {
    "bcr_patient_uuid": "cbbea9f1-396a-4bf3-b67c-2cac3394dceb",
    "patient_ID": "TCGA.44.6779",
    "bcr_drug_barcode": "TCGA-44-6779-D16027",
    "bcr_drug_uuid": "53ef5ace-fd50-4f47-a1ff-3a77d45be688",
    "form_completion_date": "2011-9-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 391,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "a534b96b-1665-444a-9308-e610f2f0e510",
    "patient_ID": "TCGA.44.7660",
    "bcr_drug_barcode": "TCGA-44-7660-D32371",
    "bcr_drug_uuid": "452ec58f-55a9-4b79-9095-1800bc34f9a8",
    "form_completion_date": "2012-5-24",
    "pharmaceutical_therapy_drug_name": "RECPRAME+AS15 ASCI",
    "clinical_trial_drug_classification": "ASCI",
    "pharmaceutical_therapy_type": "VACCINE",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4b22ad71-c585-4077-ad3c-c6e026d0c7fa",
    "patient_ID": "TCGA.44.7669",
    "bcr_drug_barcode": "TCGA-44-7669-D20479",
    "bcr_drug_uuid": "600924bb-9e59-41f0-9493-647a4c8d40e8",
    "form_completion_date": "2012-1-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 539,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 460,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "4b22ad71-c585-4077-ad3c-c6e026d0c7fa",
    "patient_ID": "TCGA.44.7669",
    "bcr_drug_barcode": "TCGA-44-7669-D20476",
    "bcr_drug_uuid": "c6e5598b-8c2a-45db-9833-9ca073f0c347",
    "form_completion_date": "2012-1-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 580
  },
  {
    "bcr_patient_uuid": "4b22ad71-c585-4077-ad3c-c6e026d0c7fa",
    "patient_ID": "TCGA.44.7669",
    "bcr_drug_barcode": "TCGA-44-7669-D20477",
    "bcr_drug_uuid": "8187bd18-8f5a-4de2-9aa1-fc17056a991c",
    "form_completion_date": "2012-1-13",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 975,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "4b22ad71-c585-4077-ad3c-c6e026d0c7fa",
    "patient_ID": "TCGA.44.7669",
    "bcr_drug_barcode": "TCGA-44-7669-D20478",
    "bcr_drug_uuid": "96593f12-a433-4978-8449-36f7fb287d10",
    "form_completion_date": "2012-1-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 539,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1900,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 1900
  },
  {
    "bcr_patient_uuid": "9b38eded-3f46-4aaa-9991-68008d97bdbe",
    "patient_ID": "TCGA.44.7670",
    "bcr_drug_barcode": "TCGA-44-7670-D20716",
    "bcr_drug_uuid": "98b04e0c-0fb1-4f87-97fc-97aed384b749",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 419
  },
  {
    "bcr_patient_uuid": "9b38eded-3f46-4aaa-9991-68008d97bdbe",
    "patient_ID": "TCGA.44.7670",
    "bcr_drug_barcode": "TCGA-44-7670-D20715",
    "bcr_drug_uuid": "cd9d0292-629c-4b64-976d-92921bc73acf",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "6d96a298-be5a-4e14-afe8-ca4b6ca298d6",
    "patient_ID": "TCGA.44.8117",
    "bcr_drug_barcode": "TCGA-44-8117-D32726",
    "bcr_drug_uuid": "19D36EEB-480F-4671-BCA8-86F6494EA205",
    "form_completion_date": "2012-6-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6d96a298-be5a-4e14-afe8-ca4b6ca298d6",
    "patient_ID": "TCGA.44.8117",
    "bcr_drug_barcode": "TCGA-44-8117-D32727",
    "bcr_drug_uuid": "EEB0D889-2452-4652-AD4C-81CCD822D2CE",
    "form_completion_date": "2012-6-13",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F61D599A-43BD-4743-9568-678317E75955",
    "patient_ID": "TCGA.44.A47F",
    "bcr_drug_barcode": "TCGA-44-A47F-D36953",
    "bcr_drug_uuid": "73D0B0CD-088C-4220-9ED5-280121CCD432",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F61D599A-43BD-4743-9568-678317E75955",
    "patient_ID": "TCGA.44.A47F",
    "bcr_drug_barcode": "TCGA-44-A47F-D36954",
    "bcr_drug_uuid": "2F7AD0AB-78F2-4B48-8180-C42A2ECE1D3A",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6c3655ca-8ae7-4ad7-b3e4-0c3ec293fba7",
    "patient_ID": "TCGA.49.4490",
    "bcr_drug_barcode": "TCGA-49-4490-D14704",
    "bcr_drug_uuid": "c7e179cb-df02-47c2-b3b6-a4877f84b06c",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0780eb43-d5b5-4c3d-9825-beacba5cc723",
    "patient_ID": "TCGA.49.4501",
    "bcr_drug_barcode": "TCGA-49-4501-D17258",
    "bcr_drug_uuid": "741831e9-9044-4e74-a539-7165b5914a80",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 664,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 694,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "50b2c647-aecd-4c81-af22-0d8116593552",
    "patient_ID": "TCGA.49.4507",
    "bcr_drug_barcode": "TCGA-49-4507-D7010",
    "bcr_drug_uuid": "5d1cdc10-8244-4d21-b7fd-b69dfe9548dc",
    "form_completion_date": "2011-2-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_tota_dose_units": "G/M2",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "50b2c647-aecd-4c81-af22-0d8116593552",
    "patient_ID": "TCGA.49.4507",
    "bcr_drug_barcode": "TCGA-49-4507-D13868",
    "bcr_drug_uuid": "96cdd9a1-d9ad-4861-88e3-d65b2d13f956",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_tota_dose_units": "G/M2",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "50b2c647-aecd-4c81-af22-0d8116593552",
    "patient_ID": "TCGA.49.4507",
    "bcr_drug_barcode": "TCGA-49-4507-D17259",
    "bcr_drug_uuid": "7c8c9fcb-3b5f-42fe-9f31-c8319cde0fc7",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a1e65587-24c1-4b41-92a7-4e1f15fffd78",
    "patient_ID": "TCGA.49.4512",
    "bcr_drug_barcode": "TCGA-49-4512-D14718",
    "bcr_drug_uuid": "11659d14-75e7-4990-bcf1-fd6d91969685",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "21fb46f9-4bbb-441c-af19-a687e9138344",
    "patient_ID": "TCGA.49.6742",
    "bcr_drug_barcode": "TCGA-49-6742-D14744",
    "bcr_drug_uuid": "3b0101a9-80a8-4824-a268-205c46c9ac31",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "21fb46f9-4bbb-441c-af19-a687e9138344",
    "patient_ID": "TCGA.49.6742",
    "bcr_drug_barcode": "TCGA-49-6742-D16680",
    "bcr_drug_uuid": "f59fb2c2-a314-4463-af34-81a5299331fc",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "21fb46f9-4bbb-441c-af19-a687e9138344",
    "patient_ID": "TCGA.49.6742",
    "bcr_drug_barcode": "TCGA-49-6742-D16679",
    "bcr_drug_uuid": "e4f03b6f-8150-4976-8b9a-1783d3aaaf2e",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 3,
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "21fb46f9-4bbb-441c-af19-a687e9138344",
    "patient_ID": "TCGA.49.6742",
    "bcr_drug_barcode": "TCGA-49-6742-D17830",
    "bcr_drug_uuid": "23b5df36-e5bf-4b57-a0db-04bc5b0c0c9c",
    "form_completion_date": "2011-10-26",
    "pharmaceutical_therapy_drug_name": "MDX-1106 CLINICAL TRIAL",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a391d49f-a822-460b-981c-6fbe1868ee38",
    "patient_ID": "TCGA.49.6743",
    "bcr_drug_barcode": "TCGA-49-6743-D14859",
    "bcr_drug_uuid": "77afb595-62de-41ce-bbd0-3e811685cfcf",
    "form_completion_date": "2011-8-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a391d49f-a822-460b-981c-6fbe1868ee38",
    "patient_ID": "TCGA.49.6743",
    "bcr_drug_barcode": "TCGA-49-6743-D16684",
    "bcr_drug_uuid": "586c3a98-5004-43da-832f-73b1ec351173",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a391d49f-a822-460b-981c-6fbe1868ee38",
    "patient_ID": "TCGA.49.6743",
    "bcr_drug_barcode": "TCGA-49-6743-D16685",
    "bcr_drug_uuid": "faeee125-10d2-46c8-81cc-75ade012acdb",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15340dd3-84ae-49fb-989a-eb212f3e73da",
    "patient_ID": "TCGA.49.6744",
    "bcr_drug_barcode": "TCGA-49-6744-D16686",
    "bcr_drug_uuid": "9954442a-123d-4dc2-a41d-966d898e3090",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9c7875ad-ab71-4d48-b2e3-e4c7a46393e9",
    "patient_ID": "TCGA.49.6745",
    "bcr_drug_barcode": "TCGA-49-6745-D16687",
    "bcr_drug_uuid": "8a687c99-eae5-4635-80db-1d8acc5bcff1",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "F809E7D9-A75E-41C9-AC2C-5BEC6FFCB4A2",
    "patient_ID": "TCGA.49.AAR2",
    "bcr_drug_barcode": "TCGA-49-AAR2-D72096",
    "bcr_drug_uuid": "5FF030BD-A154-4ACD-B9B3-057B31650269",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "765AD5A5-134B-4680-A6D4-1DD113DC47CC",
    "patient_ID": "TCGA.49.AAR4",
    "bcr_drug_barcode": "TCGA-49-AAR4-D65009",
    "bcr_drug_uuid": "4477C3EF-3A88-4C2F-955E-149887AC8C8F",
    "form_completion_date": "2014-9-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "765AD5A5-134B-4680-A6D4-1DD113DC47CC",
    "patient_ID": "TCGA.49.AAR4",
    "bcr_drug_barcode": "TCGA-49-AAR4-D65010",
    "bcr_drug_uuid": "AB97458F-B092-494A-BCEE-2FD308ED618A",
    "form_completion_date": "2014-9-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e1c55bac-bb41-4964-add5-ecd6ba04b58d",
    "patient_ID": "TCGA.50.5051",
    "bcr_drug_barcode": "TCGA-50-5051-D32021",
    "bcr_drug_uuid": "487b2e04-b00a-4221-b759-d6496965c6d9",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e1c55bac-bb41-4964-add5-ecd6ba04b58d",
    "patient_ID": "TCGA.50.5051",
    "bcr_drug_barcode": "TCGA-50-5051-D32022",
    "bcr_drug_uuid": "f3f3dcc2-08bc-4d5d-9293-f608b65f06e9",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D40457",
    "bcr_drug_uuid": "851C0D83-B6C9-427B-A391-46ED77BABB58",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D41755",
    "bcr_drug_uuid": "7404E87B-2128-4132-AB47-14402C1130F0",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1284,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D41761",
    "bcr_drug_uuid": "9AAF3C36-BC75-459E-9B70-00E485E07138",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1284,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D41762",
    "bcr_drug_uuid": "53DEAEDA-8DF5-4023-9F27-12DD16A6A2C1",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1522,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D41763",
    "bcr_drug_uuid": "C6E4C339-ED92-49E9-BE3C-37BFC3B9D570",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1522,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1649,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc3d9750-7ce0-489f-86d4-8017b7ebed29",
    "patient_ID": "TCGA.50.5055",
    "bcr_drug_barcode": "TCGA-50-5055-D41764",
    "bcr_drug_uuid": "3B8F2796-A1BC-4B2A-AC33-8108523F87C6",
    "form_completion_date": "2013-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1649,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3199cfe5-3be3-43cd-a36b-5cf2c7a9929f",
    "patient_ID": "TCGA.50.5066",
    "bcr_drug_barcode": "TCGA-50-5066-D32029",
    "bcr_drug_uuid": "5be0e05b-35a4-4283-90e3-38874324ed7a",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 567,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3199cfe5-3be3-43cd-a36b-5cf2c7a9929f",
    "patient_ID": "TCGA.50.5066",
    "bcr_drug_barcode": "TCGA-50-5066-D32030",
    "bcr_drug_uuid": "ad7d0412-3694-4490-8268-f0191cbe615c",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 567,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3199cfe5-3be3-43cd-a36b-5cf2c7a9929f",
    "patient_ID": "TCGA.50.5066",
    "bcr_drug_barcode": "TCGA-50-5066-D32031",
    "bcr_drug_uuid": "1ac70461-ad8a-48f2-b045-ce88d310315b",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 567,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "591c068f-bbb1-4df2-9abb-d1a2e4a58372",
    "patient_ID": "TCGA.50.5068",
    "bcr_drug_barcode": "TCGA-50-5068-D32058",
    "bcr_drug_uuid": "416e251e-06ba-4e59-b9b0-22db5fac92e1",
    "form_completion_date": "2012-5-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1575148b-0f63-44ee-86fd-93ae1a02be0b",
    "patient_ID": "TCGA.50.5072",
    "bcr_drug_barcode": "TCGA-50-5072-D16665",
    "bcr_drug_uuid": "4adceb9e-78a8-4ce3-b347-89e14fa7ad72",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEOADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "1575148b-0f63-44ee-86fd-93ae1a02be0b",
    "patient_ID": "TCGA.50.5072",
    "bcr_drug_barcode": "TCGA-50-5072-D16677",
    "bcr_drug_uuid": "74b1d95f-22cc-40ec-9b91-d894a1520042",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEOADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "1575148b-0f63-44ee-86fd-93ae1a02be0b",
    "patient_ID": "TCGA.50.5072",
    "bcr_drug_barcode": "TCGA-50-5072-D32061",
    "bcr_drug_uuid": "84dcbd76-6ce7-47f8-beba-5421a69c3189",
    "form_completion_date": "2012-5-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1575148b-0f63-44ee-86fd-93ae1a02be0b",
    "patient_ID": "TCGA.50.5072",
    "bcr_drug_barcode": "TCGA-50-5072-D32062",
    "bcr_drug_uuid": "26e785c9-d595-4ed7-a15b-7a0d73b47e07",
    "form_completion_date": "2012-5-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "368e23f0-e573-4547-bf5a-14080baf737b",
    "patient_ID": "TCGA.50.5930",
    "bcr_drug_barcode": "TCGA-50-5930-D32066",
    "bcr_drug_uuid": "1a5b7d4d-a7ea-4064-b672-a951d639b77e",
    "form_completion_date": "2012-5-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a0ea814-f0de-4bc4-a81a-daa000559369",
    "patient_ID": "TCGA.50.5933",
    "bcr_drug_barcode": "TCGA-50-5933-D32106",
    "bcr_drug_uuid": "668c16ce-1cba-4ca4-bccf-1a6e757231c0",
    "form_completion_date": "2012-5-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a0ea814-f0de-4bc4-a81a-daa000559369",
    "patient_ID": "TCGA.50.5933",
    "bcr_drug_barcode": "TCGA-50-5933-D32107",
    "bcr_drug_uuid": "69084794-9ae1-4394-bad1-f449c2205282",
    "form_completion_date": "2012-5-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ef42ae4c-a108-468e-beed-437cf3cf2962",
    "patient_ID": "TCGA.50.5936",
    "bcr_drug_barcode": "TCGA-50-5936-D41910",
    "bcr_drug_uuid": "26C486FA-3DCE-4BA5-A30E-544DBBDDEE25",
    "form_completion_date": "2013-4-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 188,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3f024c2-52f1-400e-946c-398f5b72e6dc",
    "patient_ID": "TCGA.50.5941",
    "bcr_drug_barcode": "TCGA-50-5941-D32131",
    "bcr_drug_uuid": "c30f3b22-ea7d-4ef7-8735-85a743e37de2",
    "form_completion_date": "2012-5-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3f024c2-52f1-400e-946c-398f5b72e6dc",
    "patient_ID": "TCGA.50.5941",
    "bcr_drug_barcode": "TCGA-50-5941-D32132",
    "bcr_drug_uuid": "1d4ba45d-7254-42be-a255-644f5af80b46",
    "form_completion_date": "2012-5-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "114a34c0-983b-4d90-9181-1823c9637a63",
    "patient_ID": "TCGA.50.6590",
    "bcr_drug_barcode": "TCGA-50-6590-D43830",
    "bcr_drug_uuid": "A075B030-D2CD-4488-9FD9-D0BFD2A087A7",
    "form_completion_date": "2013-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "114a34c0-983b-4d90-9181-1823c9637a63",
    "patient_ID": "TCGA.50.6590",
    "bcr_drug_barcode": "TCGA-50-6590-D43831",
    "bcr_drug_uuid": "A3CB9C93-4673-49EE-AB53-9823D496F039",
    "form_completion_date": "2013-6-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "82476d2d-e403-4f6b-8dd6-cc84e3329478",
    "patient_ID": "TCGA.50.6595",
    "bcr_drug_barcode": "TCGA-50-6595-D44132",
    "bcr_drug_uuid": "5CE76459-2545-4AE1-BFB7-D99A28C8576B",
    "form_completion_date": "2013-6-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9cfc1519-33e7-4145-a4ad-78b5c449853a",
    "patient_ID": "TCGA.50.8459",
    "bcr_drug_barcode": "TCGA-50-8459-D42678",
    "bcr_drug_uuid": "F90C20E9-5A78-4BD2-8814-AEFA21BA329D",
    "form_completion_date": "2013-4-26",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9cfc1519-33e7-4145-a4ad-78b5c449853a",
    "patient_ID": "TCGA.50.8459",
    "bcr_drug_barcode": "TCGA-50-8459-D42680",
    "bcr_drug_uuid": "4E2BDC04-BC96-442A-A92E-F5E7E00A1E90",
    "form_completion_date": "2013-4-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9cfc1519-33e7-4145-a4ad-78b5c449853a",
    "patient_ID": "TCGA.50.8459",
    "bcr_drug_barcode": "TCGA-50-8459-D42681",
    "bcr_drug_uuid": "C21CFFFF-014E-482A-B414-AFF5106E530C",
    "form_completion_date": "2013-4-26",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39727",
    "bcr_drug_uuid": "CABE6493-EEA3-4417-991E-E2D8BAA5D0F4",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 924,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 966,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39729",
    "bcr_drug_uuid": "28681B5B-2CCC-41DB-B342-A1BB56EE7432",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 880,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 922,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39730",
    "bcr_drug_uuid": "03D35A9D-2F9E-4DD6-BEF9-4EAE9D35C1DB",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 980,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 980,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39731",
    "bcr_drug_uuid": "F6AB7F08-1341-440F-90F1-54F3E9CF0C7F",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 803,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 861,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39732",
    "bcr_drug_uuid": "588CEFB2-2FCB-4A28-893B-35DDF6E44FB9",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 726,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 782,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39735",
    "bcr_drug_uuid": "9628B2FD-EDBE-415B-A139-7EC10C28CF7E",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39736",
    "bcr_drug_uuid": "5CDA082A-CFF9-4E2A-9C47-299425450EF8",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39737",
    "bcr_drug_uuid": "87E2D964-3168-438C-9CB9-1F81D70122AE",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 490,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39738",
    "bcr_drug_uuid": "0F25327C-C54D-4542-A956-47AFFD9D63B5",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 490,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a9cc9e-3eee-4caa-9f33-4ea64a2999ba",
    "patient_ID": "TCGA.53.7624",
    "bcr_drug_barcode": "TCGA-53-7624-D39739",
    "bcr_drug_uuid": "EAC0A9FD-301B-48F7-AFD2-499DFE2F0418",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 490,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d3ff328c-2488-47bd-8663-366b6812c7b5",
    "patient_ID": "TCGA.53.7626",
    "bcr_drug_barcode": "TCGA-53-7626-D39213",
    "bcr_drug_uuid": "0BEFAE89-775A-44A5-8352-ECB58FBCA0B3",
    "form_completion_date": "2013-1-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d3ff328c-2488-47bd-8663-366b6812c7b5",
    "patient_ID": "TCGA.53.7626",
    "bcr_drug_barcode": "TCGA-53-7626-D39214",
    "bcr_drug_uuid": "61FB2C2D-04A9-420C-881B-821008C23CCA",
    "form_completion_date": "2013-1-15",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42d208bd-cd77-4bfb-ad53-9fc072a87393",
    "patient_ID": "TCGA.53.7813",
    "bcr_drug_barcode": "TCGA-53-7813-D41063",
    "bcr_drug_uuid": "C5ECD05C-F0BC-43C9-9F9B-747BF40673B6",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 40,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42d208bd-cd77-4bfb-ad53-9fc072a87393",
    "patient_ID": "TCGA.53.7813",
    "bcr_drug_barcode": "TCGA-53-7813-D41065",
    "bcr_drug_uuid": "CE53D275-2F09-480B-B9DD-7A65EC848C45",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 40,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42d208bd-cd77-4bfb-ad53-9fc072a87393",
    "patient_ID": "TCGA.53.7813",
    "bcr_drug_barcode": "TCGA-53-7813-D41069",
    "bcr_drug_uuid": "81C8185C-C45B-44F1-A49B-4F668D595E8F",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42d208bd-cd77-4bfb-ad53-9fc072a87393",
    "patient_ID": "TCGA.53.7813",
    "bcr_drug_barcode": "TCGA-53-7813-D41072",
    "bcr_drug_uuid": "B98BBB32-9B61-4BA9-8A39-D94A205614DC",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7CA711EC-9AC0-4FA7-8A60-32AE84B8789A",
    "patient_ID": "TCGA.53.A4EZ",
    "bcr_drug_barcode": "TCGA-53-A4EZ-D40957",
    "bcr_drug_uuid": "EAB7D354-078B-4978-AD4F-A6B8C3C68D35",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7CA711EC-9AC0-4FA7-8A60-32AE84B8789A",
    "patient_ID": "TCGA.53.A4EZ",
    "bcr_drug_barcode": "TCGA-53-A4EZ-D40958",
    "bcr_drug_uuid": "58DBAB3C-5977-4D7B-8AF2-07D3D6AC5F27",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "199386c2-bb53-4fad-a1b6-59ab216a4a50",
    "patient_ID": "TCGA.55.1596",
    "bcr_drug_barcode": "TCGA-55-1596-D40545",
    "bcr_drug_uuid": "D3AC7328-D4A7-4F72-86F7-07379246F800",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "199386c2-bb53-4fad-a1b6-59ab216a4a50",
    "patient_ID": "TCGA.55.1596",
    "bcr_drug_barcode": "TCGA-55-1596-D40546",
    "bcr_drug_uuid": "5871BBDC-FC66-413D-8DE6-E44CB7DACA4D",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "996a0070-e9bf-4601-8ef7-60212108258d",
    "patient_ID": "TCGA.55.5899",
    "bcr_drug_barcode": "TCGA-55-5899-D43195",
    "bcr_drug_uuid": "C4183530-28BE-42D7-AD22-5C1C476E2388",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "996a0070-e9bf-4601-8ef7-60212108258d",
    "patient_ID": "TCGA.55.5899",
    "bcr_drug_barcode": "TCGA-55-5899-D43196",
    "bcr_drug_uuid": "314FCD94-F0EA-4781-95F8-659D257724EB",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f17d3463-af6c-42c2-a8e9-fae45f69286f",
    "patient_ID": "TCGA.55.6712",
    "bcr_drug_barcode": "TCGA-55-6712-D46640",
    "bcr_drug_uuid": "54BFE572-6DCC-4E84-884A-ED9F30AA3A5E",
    "form_completion_date": "2013-8-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f17d3463-af6c-42c2-a8e9-fae45f69286f",
    "patient_ID": "TCGA.55.6712",
    "bcr_drug_barcode": "TCGA-55-6712-D46641",
    "bcr_drug_uuid": "E61C6649-A6C8-4399-BC96-CE8A7ADA6686",
    "form_completion_date": "2013-8-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "83a6ed20-b3cf-48b9-8ed3-a080cd4951fa",
    "patient_ID": "TCGA.55.6968",
    "bcr_drug_barcode": "TCGA-55-6968-D56252",
    "bcr_drug_uuid": "FA5390E8-6281-46F2-891D-82EAF29D6654",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7cce924f-12a1-4895-9866-5d4b1869dde6",
    "patient_ID": "TCGA.55.6970",
    "bcr_drug_barcode": "TCGA-55-6970-D57906",
    "bcr_drug_uuid": "E7D92A5F-612A-448A-B26A-B4E6D018D887",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7cce924f-12a1-4895-9866-5d4b1869dde6",
    "patient_ID": "TCGA.55.6970",
    "bcr_drug_barcode": "TCGA-55-6970-D57907",
    "bcr_drug_uuid": "E03F99C9-6200-45D2-AFA8-A1289F63B270",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7cce924f-12a1-4895-9866-5d4b1869dde6",
    "patient_ID": "TCGA.55.6970",
    "bcr_drug_barcode": "TCGA-55-6970-D57908",
    "bcr_drug_uuid": "E5FF3DC9-209A-481E-BF51-DB84716FF0C4",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5af499be-d2b9-4eaf-9a9f-435dccb51917",
    "patient_ID": "TCGA.55.6979",
    "bcr_drug_barcode": "TCGA-55-6979-D40547",
    "bcr_drug_uuid": "F521F7CC-4443-4315-B2C2-B486B17D0DC5",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5af499be-d2b9-4eaf-9a9f-435dccb51917",
    "patient_ID": "TCGA.55.6979",
    "bcr_drug_barcode": "TCGA-55-6979-D40548",
    "bcr_drug_uuid": "7F10EFEE-013A-4927-8BAD-1683AED5FA99",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a45f302-5748-48f3-9dc9-66c01843a68e",
    "patient_ID": "TCGA.55.6981",
    "bcr_drug_barcode": "TCGA-55-6981-D56245",
    "bcr_drug_uuid": "C7F9FCD5-F2FB-4097-9417-19F1B5F1855B",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35cb7841-9b09-465a-90c5-e3b8a9faad49",
    "patient_ID": "TCGA.55.6982",
    "bcr_drug_barcode": "TCGA-55-6982-D46628",
    "bcr_drug_uuid": "51A05329-99B3-4DE3-BEEC-F7B7584AEE8C",
    "form_completion_date": "2013-8-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 397,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35cb7841-9b09-465a-90c5-e3b8a9faad49",
    "patient_ID": "TCGA.55.6982",
    "bcr_drug_barcode": "TCGA-55-6982-D46629",
    "bcr_drug_uuid": "F2442589-3EA6-4F5B-AA58-D61A68517EBF",
    "form_completion_date": "2013-8-13",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 397,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35cb7841-9b09-465a-90c5-e3b8a9faad49",
    "patient_ID": "TCGA.55.6982",
    "bcr_drug_barcode": "TCGA-55-6982-D46637",
    "bcr_drug_uuid": "8D09A550-760E-4CF9-8FC7-95C7C2613527",
    "form_completion_date": "2013-8-13",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 698,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 939,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54a0e4d7-c274-4569-9c25-45bbe26d7f21",
    "patient_ID": "TCGA.55.6983",
    "bcr_drug_barcode": "TCGA-55-6983-D47806",
    "bcr_drug_uuid": "A9AB2D29-B945-4946-B6F7-5EEB91B352A4",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f063ddbb-1668-40df-9ec2-b0a23ca2c389",
    "patient_ID": "TCGA.55.6984",
    "bcr_drug_barcode": "TCGA-55-6984-D45633",
    "bcr_drug_uuid": "2EEFA4BA-8311-4923-9CC0-43AEDFF385C4",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CHEMO, MULTI-AGENT, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f063ddbb-1668-40df-9ec2-b0a23ca2c389",
    "patient_ID": "TCGA.55.6984",
    "bcr_drug_barcode": "TCGA-55-6984-D45634",
    "bcr_drug_uuid": "0D8E1A7A-9075-4584-B85F-489D6DAB16F2",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 747,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4e7b2af4-b158-41a7-be22-bea227a759e6",
    "patient_ID": "TCGA.55.7227",
    "bcr_drug_barcode": "TCGA-55-7227-D65705",
    "bcr_drug_uuid": "5BC0FDF2-9109-4D86-A20D-1322832BE50E",
    "form_completion_date": "2014-9-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 409,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4e7b2af4-b158-41a7-be22-bea227a759e6",
    "patient_ID": "TCGA.55.7227",
    "bcr_drug_barcode": "TCGA-55-7227-D65706",
    "bcr_drug_uuid": "2D4D2D9E-CEB1-4321-A97C-750CB79A547B",
    "form_completion_date": "2014-9-26",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 409,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4e7b2af4-b158-41a7-be22-bea227a759e6",
    "patient_ID": "TCGA.55.7227",
    "bcr_drug_barcode": "TCGA-55-7227-D65707",
    "bcr_drug_uuid": "DEF1B875-0578-458E-9F26-D60CAAD1BB9B",
    "form_completion_date": "2014-9-26",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 442,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 876,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47811",
    "bcr_drug_uuid": "F65BFFAD-A23B-4066-829C-5D92F15865DE",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 474,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47814",
    "bcr_drug_uuid": "B212E1D8-57BE-4365-BFBA-1EA76A701912",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 579,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47815",
    "bcr_drug_uuid": "DC5037B4-AFDE-459F-8830-340492F0AA06",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 579,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47816",
    "bcr_drug_uuid": "638427FC-0F5A-4F6A-8E41-E90771270BA7",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 712,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47817",
    "bcr_drug_uuid": "5046F93F-1D01-4A67-9B87-ED115A6C742A",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 712,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659668e8-f0d9-4ff2-bbc8-9246f2ef49ab",
    "patient_ID": "TCGA.55.7281",
    "bcr_drug_barcode": "TCGA-55-7281-D47818",
    "bcr_drug_uuid": "F582DDC9-3FBE-4AC6-870A-530C86640E54",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 712,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ccfdad76-cc45-447f-bed8-ede8f6a8844d",
    "patient_ID": "TCGA.55.7283",
    "bcr_drug_barcode": "TCGA-55-7283-D46989",
    "bcr_drug_uuid": "E0804552-E06E-4FA2-A637-AFD1546794D4",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ccfdad76-cc45-447f-bed8-ede8f6a8844d",
    "patient_ID": "TCGA.55.7283",
    "bcr_drug_barcode": "TCGA-55-7283-D46990",
    "bcr_drug_uuid": "1B14B0D0-2927-4B35-9310-FE9EC2E5726C",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a7911bdc-13f1-434a-bfa3-f8ba55d15846",
    "patient_ID": "TCGA.55.7574",
    "bcr_drug_barcode": "TCGA-55-7574-D20394",
    "bcr_drug_uuid": "50bc6792-9c2d-4274-950b-9916578c4a38",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a7911bdc-13f1-434a-bfa3-f8ba55d15846",
    "patient_ID": "TCGA.55.7574",
    "bcr_drug_barcode": "TCGA-55-7574-D20393",
    "bcr_drug_uuid": "fac718aa-4cd8-4b69-a353-5c3619f96f9a",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a7911bdc-13f1-434a-bfa3-f8ba55d15846",
    "patient_ID": "TCGA.55.7574",
    "bcr_drug_barcode": "TCGA-55-7574-D64281",
    "bcr_drug_uuid": "4FE5B8E6-4EEE-41ED-986D-BD7841309AFC",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 631,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a7911bdc-13f1-434a-bfa3-f8ba55d15846",
    "patient_ID": "TCGA.55.7574",
    "bcr_drug_barcode": "TCGA-55-7574-D64282",
    "bcr_drug_uuid": "855D0B62-EF5B-4164-B03B-74957166BF47",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 631,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "055e9a43-3c00-4110-a303-e4407676bec0",
    "patient_ID": "TCGA.55.7576",
    "bcr_drug_barcode": "TCGA-55-7576-D45604",
    "bcr_drug_uuid": "081CF755-293A-4A75-8F90-BC270CBB0C58",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "055e9a43-3c00-4110-a303-e4407676bec0",
    "patient_ID": "TCGA.55.7576",
    "bcr_drug_barcode": "TCGA-55-7576-D45605",
    "bcr_drug_uuid": "12803CED-7A32-4FB2-B0BB-7351A5C61BA7",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dd46c83e-6551-485b-b935-f3beed891244",
    "patient_ID": "TCGA.55.7815",
    "bcr_drug_barcode": "TCGA-55-7815-D61496",
    "bcr_drug_uuid": "ACA058EE-8C58-4DBD-99EB-8E97EE4F6CC6",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 493,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 585,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dd46c83e-6551-485b-b935-f3beed891244",
    "patient_ID": "TCGA.55.7815",
    "bcr_drug_barcode": "TCGA-55-7815-D61499",
    "bcr_drug_uuid": "A6E48EE4-3A3F-49A9-8FEF-18D08A8F7BE4",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb",
    "patient_ID": "TCGA.55.7910",
    "bcr_drug_barcode": "TCGA-55-7910-D66141",
    "bcr_drug_uuid": "76D8449C-257D-474B-A830-EDE15DAE2DDD",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69dba721-a168-47a4-b7ff-80a448bad654",
    "patient_ID": "TCGA.55.7914",
    "bcr_drug_barcode": "TCGA-55-7914-D59093",
    "bcr_drug_uuid": "6C2F2B61-58BA-4970-BC91-DF0902E87C39",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69dba721-a168-47a4-b7ff-80a448bad654",
    "patient_ID": "TCGA.55.7914",
    "bcr_drug_barcode": "TCGA-55-7914-D59094",
    "bcr_drug_uuid": "5EEF9195-2694-425E-9C08-5C82278C9C16",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69dba721-a168-47a4-b7ff-80a448bad654",
    "patient_ID": "TCGA.55.7914",
    "bcr_drug_barcode": "TCGA-55-7914-D59095",
    "bcr_drug_uuid": "6A7819DA-BFA9-4BCF-BA27-3DC196B9EF70",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67dbe286-edb3-4d07-8f74-9e5254f01945",
    "patient_ID": "TCGA.55.7994",
    "bcr_drug_barcode": "TCGA-55-7994-D47824",
    "bcr_drug_uuid": "711DE5E8-64BE-4AE2-9B48-BE206A7960AC",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67dbe286-edb3-4d07-8f74-9e5254f01945",
    "patient_ID": "TCGA.55.7994",
    "bcr_drug_barcode": "TCGA-55-7994-D47825",
    "bcr_drug_uuid": "C4E8D500-182E-4A75-9E3A-5EC4E60DD487",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "abd6647b-d2eb-404d-8283-443e92addf55",
    "patient_ID": "TCGA.55.7995",
    "bcr_drug_barcode": "TCGA-55-7995-D65702",
    "bcr_drug_uuid": "39A1C7F0-0574-41C9-98D5-D0D7AF66D866",
    "form_completion_date": "2014-9-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 525,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "abd6647b-d2eb-404d-8283-443e92addf55",
    "patient_ID": "TCGA.55.7995",
    "bcr_drug_barcode": "TCGA-55-7995-D65703",
    "bcr_drug_uuid": "386B9E74-6618-451B-8F90-9F3BFDE51CD1",
    "form_completion_date": "2014-9-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 525,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95fa64b0-91e1-4427-b81a-53c47a053563",
    "patient_ID": "TCGA.55.8205",
    "bcr_drug_barcode": "TCGA-55-8205-D59042",
    "bcr_drug_uuid": "0EC2801F-BAED-4EC4-973E-BE336BDA8894",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95fa64b0-91e1-4427-b81a-53c47a053563",
    "patient_ID": "TCGA.55.8205",
    "bcr_drug_barcode": "TCGA-55-8205-D59043",
    "bcr_drug_uuid": "E6B41481-C1F8-465D-8757-E2F2F2B0A4DB",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95fa64b0-91e1-4427-b81a-53c47a053563",
    "patient_ID": "TCGA.55.8205",
    "bcr_drug_barcode": "TCGA-55-8205-D59044",
    "bcr_drug_uuid": "DA27B801-8C82-4033-87DD-101B032FF22E",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b36b7567-30d3-4d0c-84c4-b203986e0fdb",
    "patient_ID": "TCGA.55.8301",
    "bcr_drug_barcode": "TCGA-55-8301-D56263",
    "bcr_drug_uuid": "81EAC4EA-9876-4E67-B2D2-230762F91928",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b36b7567-30d3-4d0c-84c4-b203986e0fdb",
    "patient_ID": "TCGA.55.8301",
    "bcr_drug_barcode": "TCGA-55-8301-D56264",
    "bcr_drug_uuid": "D6B06699-89FF-4995-95D5-D7B9B1095651",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f59e5a76-f803-470b-910c-a897a149d939",
    "patient_ID": "TCGA.55.8505",
    "bcr_drug_barcode": "TCGA-55-8505-D47799",
    "bcr_drug_uuid": "E1832AA8-C7E7-4BF8-BF54-E7BC3EEF3619",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f59e5a76-f803-470b-910c-a897a149d939",
    "patient_ID": "TCGA.55.8505",
    "bcr_drug_barcode": "TCGA-55-8505-D47801",
    "bcr_drug_uuid": "57354507-5DEF-495C-8B74-0E7773AC1C4B",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bab335f9-b241-41a7-b107-79b9676b37b8",
    "patient_ID": "TCGA.55.8508",
    "bcr_drug_barcode": "TCGA-55-8508-D66138",
    "bcr_drug_uuid": "09E9C95E-CD77-45FB-AF89-25C96E794AB8",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bab335f9-b241-41a7-b107-79b9676b37b8",
    "patient_ID": "TCGA.55.8508",
    "bcr_drug_barcode": "TCGA-55-8508-D66139",
    "bcr_drug_uuid": "E05A3BB7-4A18-439D-BDD9-4DBBA8128428",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3fd20b2-e001-44ab-9716-754e5ae70808",
    "patient_ID": "TCGA.55.8513",
    "bcr_drug_barcode": "TCGA-55-8513-D64284",
    "bcr_drug_uuid": "2FEFA276-5D66-46D2-B73C-6138E1E304B9",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 460,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3fd20b2-e001-44ab-9716-754e5ae70808",
    "patient_ID": "TCGA.55.8513",
    "bcr_drug_barcode": "TCGA-55-8513-D64285",
    "bcr_drug_uuid": "3D2150F8-FBEF-4037-83F8-E9BB0CD7746E",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06fe7f3e-4edd-4150-981c-93787ea19b39",
    "patient_ID": "TCGA.55.8615",
    "bcr_drug_barcode": "TCGA-55-8615-D56256",
    "bcr_drug_uuid": "C3E3F94E-7959-47E7-941B-5092013166FF",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06fe7f3e-4edd-4150-981c-93787ea19b39",
    "patient_ID": "TCGA.55.8615",
    "bcr_drug_barcode": "TCGA-55-8615-D56257",
    "bcr_drug_uuid": "BCB6362E-FD58-49FE-82E2-ACD98A53F2D7",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06fe7f3e-4edd-4150-981c-93787ea19b39",
    "patient_ID": "TCGA.55.8615",
    "bcr_drug_barcode": "TCGA-55-8615-D56258",
    "bcr_drug_uuid": "E08B7831-B7A9-4EC0-9D20-39B36957E6C1",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 234,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 324,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06fe7f3e-4edd-4150-981c-93787ea19b39",
    "patient_ID": "TCGA.55.8615",
    "bcr_drug_barcode": "TCGA-55-8615-D56259",
    "bcr_drug_uuid": "2B2ABC4D-DB6C-4DBC-9DD8-519DEE12F63C",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 234,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 416,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "32D9935A-F5CD-43B3-88BD-09E6E2B9090D",
    "patient_ID": "TCGA.55.A48X",
    "bcr_drug_barcode": "TCGA-55-A48X-D61502",
    "bcr_drug_uuid": "D62B9942-18BB-46BB-9CD2-27E149A14B9D",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "32D9935A-F5CD-43B3-88BD-09E6E2B9090D",
    "patient_ID": "TCGA.55.A48X",
    "bcr_drug_barcode": "TCGA-55-A48X-D61503",
    "bcr_drug_uuid": "119EF573-924B-4764-935E-8156AEC3B7B8",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12C07138-E3FA-418A-89E3-628DA12BC99E",
    "patient_ID": "TCGA.55.A48Y",
    "bcr_drug_barcode": "TCGA-55-A48Y-D59059",
    "bcr_drug_uuid": "47E0007B-5A41-4E22-8E2B-2483E168CA99",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12C07138-E3FA-418A-89E3-628DA12BC99E",
    "patient_ID": "TCGA.55.A48Y",
    "bcr_drug_barcode": "TCGA-55-A48Y-D59060",
    "bcr_drug_uuid": "A497B509-E9BB-4278-851A-F25CB653F363",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16D3C1C1-CF3A-44B6-B564-8AE5464B243D",
    "patient_ID": "TCGA.55.A48Z",
    "bcr_drug_barcode": "TCGA-55-A48Z-D59069",
    "bcr_drug_uuid": "AFA50190-D879-4A5D-A4A9-F1A7F1E161AA",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16D3C1C1-CF3A-44B6-B564-8AE5464B243D",
    "patient_ID": "TCGA.55.A48Z",
    "bcr_drug_barcode": "TCGA-55-A48Z-D59070",
    "bcr_drug_uuid": "1B807520-A86F-4B84-8830-F8DDCC3231BE",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B89DE053-D253-447F-952E-9A2EDCF6BCA5",
    "patient_ID": "TCGA.55.A490",
    "bcr_drug_barcode": "TCGA-55-A490-D59079",
    "bcr_drug_uuid": "A6D28342-BD3F-4814-B710-BFBA6B19D0B3",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B89DE053-D253-447F-952E-9A2EDCF6BCA5",
    "patient_ID": "TCGA.55.A490",
    "bcr_drug_barcode": "TCGA-55-A490-D59080",
    "bcr_drug_uuid": "2A35CBA5-76D7-4EAC-AF33-941BD871E623",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "742e0e32-25b5-4d41-8bf5-364b571cfd93",
    "patient_ID": "TCGA.62.8394",
    "bcr_drug_barcode": "TCGA-62-8394-D33506",
    "bcr_drug_uuid": "66473842-A8EB-488E-BDE4-81A6B15B53B9",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "742e0e32-25b5-4d41-8bf5-364b571cfd93",
    "patient_ID": "TCGA.62.8394",
    "bcr_drug_barcode": "TCGA-62-8394-D40459",
    "bcr_drug_uuid": "16DB8141-F66A-4A03-ABB6-CF51C96CC392",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2fabeb98-05e3-4f55-97f5-fbc675e25a3d",
    "patient_ID": "TCGA.62.8398",
    "bcr_drug_barcode": "TCGA-62-8398-D33507",
    "bcr_drug_uuid": "316E364F-9824-4D22-AB44-6C9181EF3AAA",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2fabeb98-05e3-4f55-97f5-fbc675e25a3d",
    "patient_ID": "TCGA.62.8398",
    "bcr_drug_barcode": "TCGA-62-8398-D40458",
    "bcr_drug_uuid": "BB70829B-5995-4D0D-ABEF-22D1AD108527",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "VINORELBIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E00A60D7-4253-443D-A187-680AD0931349",
    "patient_ID": "TCGA.62.A46S",
    "bcr_drug_barcode": "TCGA-62-A46S-D36326",
    "bcr_drug_uuid": "A78743CC-2953-4ECE-A4AE-0C60106B1A3C",
    "form_completion_date": "2012-10-31",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "E00A60D7-4253-443D-A187-680AD0931349",
    "patient_ID": "TCGA.62.A46S",
    "bcr_drug_barcode": "TCGA-62-A46S-D40574",
    "bcr_drug_uuid": "C9C16A96-C581-4DB9-B7F3-5B6ACCC39DFC",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "793649E5-F479-4D64-8723-2EF488FE0FD9",
    "patient_ID": "TCGA.62.A46U",
    "bcr_drug_barcode": "TCGA-62-A46U-D36362",
    "bcr_drug_uuid": "7D7C9C05-6714-45E1-BFA5-C1EC33D20EBF",
    "form_completion_date": "2012-10-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "793649E5-F479-4D64-8723-2EF488FE0FD9",
    "patient_ID": "TCGA.62.A46U",
    "bcr_drug_barcode": "TCGA-62-A46U-D40575",
    "bcr_drug_uuid": "A6950970-9BFA-42C0-99E7-E2B841A95279",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "562A562B-CA03-44AC-B282-B51B457D8DAE",
    "patient_ID": "TCGA.62.A46Y",
    "bcr_drug_barcode": "TCGA-62-A46Y-D36365",
    "bcr_drug_uuid": "55FA6477-77DE-4CB4-9BDF-8AC7045569AA",
    "form_completion_date": "2012-10-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "562A562B-CA03-44AC-B282-B51B457D8DAE",
    "patient_ID": "TCGA.62.A46Y",
    "bcr_drug_barcode": "TCGA-62-A46Y-D40578",
    "bcr_drug_uuid": "06D3010F-39E9-4C9D-96D8-EAE50C4C705B",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0075437E-BA1A-46BE-86D6-9773209A2B5E",
    "patient_ID": "TCGA.62.A471",
    "bcr_drug_barcode": "TCGA-62-A471-D36369",
    "bcr_drug_uuid": "0B09C8A2-1EDD-4523-9B04-7C6DCA69D4CE",
    "form_completion_date": "2012-10-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0075437E-BA1A-46BE-86D6-9773209A2B5E",
    "patient_ID": "TCGA.62.A471",
    "bcr_drug_barcode": "TCGA-62-A471-D40576",
    "bcr_drug_uuid": "AB370E23-6CB3-4C2D-AAEE-F18B9832C078",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0075437E-BA1A-46BE-86D6-9773209A2B5E",
    "patient_ID": "TCGA.62.A471",
    "bcr_drug_barcode": "TCGA-62-A471-D40577",
    "bcr_drug_uuid": "8E2B3458-E311-41FF-BA45-78E93803E232",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8a16ddb3-4861-4128-bed9-0b1f94fe8cf7",
    "patient_ID": "TCGA.64.1677",
    "bcr_drug_barcode": "TCGA-64-1677-D8696",
    "bcr_drug_uuid": "8a35805b-e7b8-4f10-8aae-d78f856a372e",
    "form_completion_date": "2011-2-18",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8a16ddb3-4861-4128-bed9-0b1f94fe8cf7",
    "patient_ID": "TCGA.64.1677",
    "bcr_drug_barcode": "TCGA-64-1677-D8692",
    "bcr_drug_uuid": "a4d38c0d-dd9a-4143-ae98-9be774d485c5",
    "form_completion_date": "2011-2-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 425,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8a16ddb3-4861-4128-bed9-0b1f94fe8cf7",
    "patient_ID": "TCGA.64.1677",
    "bcr_drug_barcode": "TCGA-64-1677-D8693",
    "bcr_drug_uuid": "654eaa9e-2e91-4ef6-9e36-02a237406432",
    "form_completion_date": "2011-2-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 1600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f77cf4d3-9829-4fd3-95a1-b29aed9e94b8",
    "patient_ID": "TCGA.64.1678",
    "bcr_drug_barcode": "TCGA-64-1678-D4372",
    "bcr_drug_uuid": "52f1e822-e632-41d3-8878-da3dcc2611d1",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f77cf4d3-9829-4fd3-95a1-b29aed9e94b8",
    "patient_ID": "TCGA.64.1678",
    "bcr_drug_barcode": "TCGA-64-1678-D4374",
    "bcr_drug_uuid": "8e66e3b4-e400-4d79-b659-1633ac4dc232",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "81a0b2ff-a3d3-41bb-9ce6-765e6ae894af",
    "patient_ID": "TCGA.64.1679",
    "bcr_drug_barcode": "TCGA-64-1679-D20371",
    "bcr_drug_uuid": "42c98e6b-93c1-4647-8b65-82716be9d850",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "81a0b2ff-a3d3-41bb-9ce6-765e6ae894af",
    "patient_ID": "TCGA.64.1679",
    "bcr_drug_barcode": "TCGA-64-1679-D20370",
    "bcr_drug_uuid": "a1d5051d-3893-4e77-b34c-88e599bda776",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1ab7ad70-0f80-41d8-8efa-3baebc8223cc",
    "patient_ID": "TCGA.64.1680",
    "bcr_drug_barcode": "TCGA-64-1680-D4377",
    "bcr_drug_uuid": "16e53760-5ca6-4a73-b332-a900418c84d6",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c583fdd1-8cd2-4c15-a23e-0644261f65da",
    "patient_ID": "TCGA.64.1681",
    "bcr_drug_barcode": "TCGA-64-1681-D20366",
    "bcr_drug_uuid": "27af4417-3bc7-4992-9965-9f4b6c1f6434",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 481,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c8544fb3-b26e-4672-bb81-a271db724b04",
    "patient_ID": "TCGA.64.5775",
    "bcr_drug_barcode": "TCGA-64-5775-D11422",
    "bcr_drug_uuid": "7c68848c-8750-490a-811a-2d79abb12d7a",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c8544fb3-b26e-4672-bb81-a271db724b04",
    "patient_ID": "TCGA.64.5775",
    "bcr_drug_barcode": "TCGA-64-5775-D11419",
    "bcr_drug_uuid": "4d9280cc-1045-45ad-9f20-9ea5dc1ea652",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 28,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742",
    "patient_ID": "TCGA.64.5778",
    "bcr_drug_barcode": "TCGA-64-5778-D31472",
    "bcr_drug_uuid": "fc448027-ade7-47c9-8323-907f35fc2702",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1174,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a",
    "patient_ID": "TCGA.64.5779",
    "bcr_drug_barcode": "TCGA-64-5779-D11376",
    "bcr_drug_uuid": "621a2148-00ec-4c00-a0bc-980442ab9522",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a",
    "patient_ID": "TCGA.64.5779",
    "bcr_drug_barcode": "TCGA-64-5779-D11375",
    "bcr_drug_uuid": "c0d60743-bdf0-436e-9702-4e8ce35c248d",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a",
    "patient_ID": "TCGA.64.5779",
    "bcr_drug_barcode": "TCGA-64-5779-D31475",
    "bcr_drug_uuid": "d2824bc2-e94d-4926-9b6b-0600e519bb80",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a",
    "patient_ID": "TCGA.64.5779",
    "bcr_drug_barcode": "TCGA-64-5779-D31476",
    "bcr_drug_uuid": "b55016e7-e7a7-430d-93e0-377e6fb2fb50",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D11406",
    "bcr_drug_uuid": "83cf163f-43dc-4a75-9ed6-a433a2226488",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 1250,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D11407",
    "bcr_drug_uuid": "92010938-ac4a-4ab1-b25e-dba6632b92ba",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 3,
    "drug_units": "MG/KG",
    "drug_dose": 15,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D11405",
    "bcr_drug_uuid": "4ffd6d8f-3ded-49b0-a532-d0fb97ef1033",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D31491",
    "bcr_drug_uuid": "04bd06de-39e1-47d6-bdb4-de3aeccf9f63",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D31492",
    "bcr_drug_uuid": "86ff15d3-47d0-47e5-ad61-cded2ed6345d",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41c4c704-825e-49f5-9d54-dbd7d30725e0",
    "patient_ID": "TCGA.64.5781",
    "bcr_drug_barcode": "TCGA-64-5781-D31493",
    "bcr_drug_uuid": "acadc104-cf2b-4ac0-8598-f4e35edbb3d1",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D11426",
    "bcr_drug_uuid": "c5c5b4f0-2f37-4d6a-b486-29c7638c00e5",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D11429",
    "bcr_drug_uuid": "96ec4fe4-fb5e-4fd3-903d-aef8816562c7",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D11431",
    "bcr_drug_uuid": "0750d485-4281-41ea-a62c-7860f4e50db9",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D11434",
    "bcr_drug_uuid": "35b6dcb0-3140-4e22-8857-a5adcc1bd27f",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D31481",
    "bcr_drug_uuid": "65568c73-1054-4a71-bb8c-ecdd22eaf03e",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D31482",
    "bcr_drug_uuid": "f1173777-7ce0-422c-8f6f-e4216233f93e",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D31483",
    "bcr_drug_uuid": "20c7f73f-0afe-4e4a-b887-93338bfd9df6",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a65700c2-e58c-4fd4-aeb1-5686b8f4d212",
    "patient_ID": "TCGA.64.5815",
    "bcr_drug_barcode": "TCGA-64-5815-D31484",
    "bcr_drug_uuid": "4878b403-b86b-448f-a98c-f33fb9f7ea01",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "ALMITA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dbd5b0de-94c9-45dd-afb3-6820a7ecaca2",
    "patient_ID": "TCGA.67.6215",
    "bcr_drug_barcode": "TCGA-67-6215-D13739",
    "bcr_drug_uuid": "f689f65f-4ee1-458b-a0a3-0830819796fc",
    "form_completion_date": "2011-7-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dbd5b0de-94c9-45dd-afb3-6820a7ecaca2",
    "patient_ID": "TCGA.67.6215",
    "bcr_drug_barcode": "TCGA-67-6215-D13760",
    "bcr_drug_uuid": "7199c0c9-6baf-4418-a719-d2c648677db4",
    "form_completion_date": "2011-7-12",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "108a71cf-b9db-47cd-aa74-c03ec989b41b",
    "patient_ID": "TCGA.67.6217",
    "bcr_drug_barcode": "TCGA-67-6217-D13740",
    "bcr_drug_uuid": "912f0718-4f53-4ab2-9972-8bbadf753d8d",
    "form_completion_date": "2011-7-11",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8981f0c9-7155-4c96-bf77-7d40fe404323",
    "patient_ID": "TCGA.69.7760",
    "bcr_drug_barcode": "TCGA-69-7760-D20981",
    "bcr_drug_uuid": "94bb8b11-881e-449b-8206-95458a4e6762",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 588.6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8981f0c9-7155-4c96-bf77-7d40fe404323",
    "patient_ID": "TCGA.69.7760",
    "bcr_drug_barcode": "TCGA-69-7760-D21152",
    "bcr_drug_uuid": "5fa9b68b-32b6-4df9-a9a8-01cc626473d6",
    "form_completion_date": "2012-2-2",
    "pharmaceutical_therapy_drug_name": "PEMETREXED DISODIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 905,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "77828a90-8e2a-4664-b674-d837e6e34fe4",
    "patient_ID": "TCGA.69.7761",
    "bcr_drug_barcode": "TCGA-69-7761-D29253",
    "bcr_drug_uuid": "827ec9b8-ee79-4f14-8cb1-001249e90c74",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "77828a90-8e2a-4664-b674-d837e6e34fe4",
    "patient_ID": "TCGA.69.7761",
    "bcr_drug_barcode": "TCGA-69-7761-D29256",
    "bcr_drug_uuid": "15c9dc00-5f02-401f-96c4-e5098a9d7f91",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bcf2e591-9dae-440f-bd03-5f27c57db741",
    "patient_ID": "TCGA.69.7765",
    "bcr_drug_barcode": "TCGA-69-7765-D21012",
    "bcr_drug_uuid": "dd4077d4-121a-4548-b9cb-131aee81484b",
    "form_completion_date": "2012-1-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bcf2e591-9dae-440f-bd03-5f27c57db741",
    "patient_ID": "TCGA.69.7765",
    "bcr_drug_barcode": "TCGA-69-7765-D29489",
    "bcr_drug_uuid": "5e1b818b-56f7-4340-91eb-d490e7bc91a2",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc9eaaa0-0bfd-46d0-994f-310826879da4",
    "patient_ID": "TCGA.69.7973",
    "bcr_drug_barcode": "TCGA-69-7973-D30332",
    "bcr_drug_uuid": "2B5DC03D-AFEF-4C32-BB62-02A37D57897F",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc9eaaa0-0bfd-46d0-994f-310826879da4",
    "patient_ID": "TCGA.69.7973",
    "bcr_drug_barcode": "TCGA-69-7973-D30341",
    "bcr_drug_uuid": "8C513402-CD6E-424D-9844-E3390F02D0C3",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc9eaaa0-0bfd-46d0-994f-310826879da4",
    "patient_ID": "TCGA.69.7973",
    "bcr_drug_barcode": "TCGA-69-7973-D30344",
    "bcr_drug_uuid": "D947DBDE-9875-4B03-AE2A-F2B3AE12CCD8",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc9eaaa0-0bfd-46d0-994f-310826879da4",
    "patient_ID": "TCGA.69.7973",
    "bcr_drug_barcode": "TCGA-69-7973-D30346",
    "bcr_drug_uuid": "8C538EDD-BE6D-4A7E-8936-5487EB1589D3",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3e1df30f-744a-41e9-a169-7dbbff66622e",
    "patient_ID": "TCGA.69.7974",
    "bcr_drug_barcode": "TCGA-69-7974-D30366",
    "bcr_drug_uuid": "FF1F92D3-3742-477D-8C65-C4AC2811A0C2",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3e1df30f-744a-41e9-a169-7dbbff66622e",
    "patient_ID": "TCGA.69.7974",
    "bcr_drug_barcode": "TCGA-69-7974-D30368",
    "bcr_drug_uuid": "E368B4BF-E5C5-4E85-BDA5-8A7A50246BA7",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3e1df30f-744a-41e9-a169-7dbbff66622e",
    "patient_ID": "TCGA.69.7974",
    "bcr_drug_barcode": "TCGA-69-7974-D30370",
    "bcr_drug_uuid": "D76675FA-0F02-4B08-91C1-D014BBC62EF2",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4",
    "patient_ID": "TCGA.69.8253",
    "bcr_drug_barcode": "TCGA-69-8253-D32564",
    "bcr_drug_uuid": "E2D64977-0DCC-4BF6-A66E-7D40AF9263AF",
    "form_completion_date": "2012-6-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4",
    "patient_ID": "TCGA.69.8253",
    "bcr_drug_barcode": "TCGA-69-8253-D32565",
    "bcr_drug_uuid": "3AF5EEC9-47EC-4D16-8427-FE85149B06A5",
    "form_completion_date": "2012-6-1",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f4f2ff3-3c02-4281-a398-b0d0955e58eb",
    "patient_ID": "TCGA.69.8453",
    "bcr_drug_barcode": "TCGA-69-8453-D38749",
    "bcr_drug_uuid": "ADF240B0-E64F-4B67-B0D0-67705AEA4763",
    "form_completion_date": "2013-2-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f4f2ff3-3c02-4281-a398-b0d0955e58eb",
    "patient_ID": "TCGA.69.8453",
    "bcr_drug_barcode": "TCGA-69-8453-D52053",
    "bcr_drug_uuid": "668F81DB-46F6-4AF3-AA38-ECC71EC50D0A",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f4f2ff3-3c02-4281-a398-b0d0955e58eb",
    "patient_ID": "TCGA.69.8453",
    "bcr_drug_barcode": "TCGA-69-8453-D52058",
    "bcr_drug_uuid": "D34529C7-817F-493F-9304-FFD96B855AFE",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f4f2ff3-3c02-4281-a398-b0d0955e58eb",
    "patient_ID": "TCGA.69.8453",
    "bcr_drug_barcode": "TCGA-69-8453-D38750",
    "bcr_drug_uuid": "E78C20DE-6F02-4FAE-9948-42E954BBFACB",
    "form_completion_date": "2014-3-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67FA3E41-C7C6-44C5-9E67-6BCB2715AACC",
    "patient_ID": "TCGA.69.A59K",
    "bcr_drug_barcode": "TCGA-69-A59K-D40359",
    "bcr_drug_uuid": "095F50E9-408C-4353-B7D6-339A2BBC1895",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67FA3E41-C7C6-44C5-9E67-6BCB2715AACC",
    "patient_ID": "TCGA.69.A59K",
    "bcr_drug_barcode": "TCGA-69-A59K-D40360",
    "bcr_drug_uuid": "EE6D5CA4-FDD0-45B6-A767-D5B34DE311ED",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b7cd595-e7f9-45a8-b736-a8c7c42d9539",
    "patient_ID": "TCGA.71.6725",
    "bcr_drug_barcode": "TCGA-71-6725-D70932",
    "bcr_drug_uuid": "C96AEDBF-65F7-4278-9841-02DE35F2FBD4",
    "form_completion_date": "2015-3-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b7cd595-e7f9-45a8-b736-a8c7c42d9539",
    "patient_ID": "TCGA.71.6725",
    "bcr_drug_barcode": "TCGA-71-6725-D70933",
    "bcr_drug_uuid": "58FFFDD4-06DF-4156-903D-ECAA85C8D3B5",
    "form_completion_date": "2015-3-10",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12858",
    "bcr_drug_uuid": "e1e21cb8-57eb-41c0-bc61-810f106edb69",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12830",
    "bcr_drug_uuid": "8cfd7bb0-b951-48a1-bb37-5452ea0cbf5a",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 581,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12854",
    "bcr_drug_uuid": "4a12034c-0bf9-4eb9-a160-0cf1abb40e59",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 581,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12862",
    "bcr_drug_uuid": "0d2c7085-2781-4e8e-8b42-63ec7e58b646",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "CYC-116/CYCLOCEL",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 657,
    "drug_cycles": 3,
    "pharma_type_other": "AURORA KINASE INHIBITOR - PROTOCOL THERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROTOCOL",
    "drug_total_dose": 15120
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12823",
    "bcr_drug_uuid": "9025783d-e657-4c73-a5f6-e9ee2e60a789",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 410,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 452,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12827",
    "bcr_drug_uuid": "cd7e24d6-b03d-4d4d-aa1d-1f3263695c72",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "DOCETOXEL/TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 473,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 494,
    "drug_cycles": 4,
    "drug_units": "G/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12430",
    "bcr_drug_uuid": "a14661c5-aff8-4e99-af96-b96b3dafcf52",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "ERLOTONIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "cd0dc947-b708-464e-beb7-954c9d4583e7",
    "patient_ID": "TCGA.73.4659",
    "bcr_drug_barcode": "TCGA-73-4659-D12421",
    "bcr_drug_uuid": "98e093a8-64cb-4848-a1c5-0cb8c8b550f9",
    "form_completion_date": "2010-12-3",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 298,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "4c31127e-d095-4978-9dac-35153c27f6ed",
    "patient_ID": "TCGA.73.4666",
    "bcr_drug_barcode": "TCGA-73-4666-D13245",
    "bcr_drug_uuid": "d23a0b04-32a9-428b-b725-89722eeb2d40",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4c31127e-d095-4978-9dac-35153c27f6ed",
    "patient_ID": "TCGA.73.4666",
    "bcr_drug_barcode": "TCGA-73-4666-D13246",
    "bcr_drug_uuid": "6e0afbee-c9ca-4103-850d-1c7e07b03d56",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b2285924-9813-4f46-bb8f-91a0efd8a9b6",
    "patient_ID": "TCGA.73.4668",
    "bcr_drug_barcode": "TCGA-73-4668-D7959",
    "bcr_drug_uuid": "b2535da4-0fa6-43d0-92c1-05717101d861",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 369,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 1000,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b2285924-9813-4f46-bb8f-91a0efd8a9b6",
    "patient_ID": "TCGA.73.4668",
    "bcr_drug_barcode": "TCGA-73-4668-D7956",
    "bcr_drug_uuid": "0a6f15d0-842e-4da6-8de0-8374e694987a",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4320
  },
  {
    "bcr_patient_uuid": "b2285924-9813-4f46-bb8f-91a0efd8a9b6",
    "patient_ID": "TCGA.73.4668",
    "bcr_drug_barcode": "TCGA-73-4668-D7957",
    "bcr_drug_uuid": "9eb9db2a-643c-49ca-ab5b-7dd90adcbbc5",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2184
  },
  {
    "bcr_patient_uuid": "b2285924-9813-4f46-bb8f-91a0efd8a9b6",
    "patient_ID": "TCGA.73.4668",
    "bcr_drug_barcode": "TCGA-73-4668-D7960",
    "bcr_drug_uuid": "cca6912e-8a06-4270-8717-86cfd00d2ec7",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 369,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "1b354837-4925-4480-ac32-6b44d0957314",
    "patient_ID": "TCGA.73.4670",
    "bcr_drug_barcode": "TCGA-73-4670-D12988",
    "bcr_drug_uuid": "634e1395-f22a-4b7b-80d6-9f2d2929ccd1",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 308,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 308
  },
  {
    "bcr_patient_uuid": "1b354837-4925-4480-ac32-6b44d0957314",
    "patient_ID": "TCGA.73.4670",
    "bcr_drug_barcode": "TCGA-73-4670-D12984",
    "bcr_drug_uuid": "fce5249c-69e4-43b1-ba19-7261731a8a90",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 538,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2152
  },
  {
    "bcr_patient_uuid": "1b354837-4925-4480-ac32-6b44d0957314",
    "patient_ID": "TCGA.73.4670",
    "bcr_drug_barcode": "TCGA-73-4670-D12986",
    "bcr_drug_uuid": "2aaeb964-d8d0-4811-85a8-5b26948bf157",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 680,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2720
  },
  {
    "bcr_patient_uuid": "1b354837-4925-4480-ac32-6b44d0957314",
    "patient_ID": "TCGA.73.4670",
    "bcr_drug_barcode": "TCGA-73-4670-D12987",
    "bcr_drug_uuid": "06e09d14-17d7-4d81-a98c-780ac3ff2162",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 930,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3720
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71056",
    "bcr_drug_uuid": "13B8CCE4-8461-4A03-A567-E5922A9A11A4",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71057",
    "bcr_drug_uuid": "3C9951FA-7567-4A17-8ED5-031F790060D7",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71058",
    "bcr_drug_uuid": "25DC92F4-A154-4196-9D5F-4BE559E42ABA",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71059",
    "bcr_drug_uuid": "1C265224-D738-4F25-8103-9B037F9C9447",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71060",
    "bcr_drug_uuid": "DC1FC3CB-3680-4D2A-86C2-B9DBC184D6BC",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71061",
    "bcr_drug_uuid": "08130C1E-5BB6-4080-939E-11D5E4215EEF",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae39e358-08d7-4367-ae68-82b469e791e4",
    "patient_ID": "TCGA.73.4675",
    "bcr_drug_barcode": "TCGA-73-4675-D71062",
    "bcr_drug_uuid": "3BF6C8DC-1CB9-4686-987C-7DA51220B8A3",
    "form_completion_date": "2015-3-17",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 592,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 676,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "195a5afb-b79f-44d2-9d12-884487630c2b",
    "patient_ID": "TCGA.73.4676",
    "bcr_drug_barcode": "TCGA-73-4676-D12587",
    "bcr_drug_uuid": "1eba36d1-01f8-4cd4-b90d-98cc949417f0",
    "form_completion_date": "2011-6-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "195a5afb-b79f-44d2-9d12-884487630c2b",
    "patient_ID": "TCGA.73.4676",
    "bcr_drug_barcode": "TCGA-73-4676-D12586",
    "bcr_drug_uuid": "48957710-70e7-4615-9717-fb2a9174b210",
    "form_completion_date": "2011-6-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "195a5afb-b79f-44d2-9d12-884487630c2b",
    "patient_ID": "TCGA.73.4676",
    "bcr_drug_barcode": "TCGA-73-4676-D12585",
    "bcr_drug_uuid": "0989c0d2-81e6-4f78-93b4-3a7f35ba221b",
    "form_completion_date": "2011-6-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -40,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "195a5afb-b79f-44d2-9d12-884487630c2b",
    "patient_ID": "TCGA.73.4676",
    "bcr_drug_barcode": "TCGA-73-4676-D12556",
    "bcr_drug_uuid": "da213998-af4a-4a37-967e-419359cab836",
    "form_completion_date": "2011-6-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -40,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "ad74c0e8-8878-4efc-997d-981cd547bc5b",
    "patient_ID": "TCGA.73.7498",
    "bcr_drug_barcode": "TCGA-73-7498-D32539",
    "bcr_drug_uuid": "0809DF70-4919-4CE8-926D-7348AC6DC9B7",
    "form_completion_date": "2012-5-31",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad74c0e8-8878-4efc-997d-981cd547bc5b",
    "patient_ID": "TCGA.73.7498",
    "bcr_drug_barcode": "TCGA-73-7498-D32540",
    "bcr_drug_uuid": "DE51B406-96D0-467C-9B21-E48C69E073BA",
    "form_completion_date": "2012-5-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad74c0e8-8878-4efc-997d-981cd547bc5b",
    "patient_ID": "TCGA.73.7498",
    "bcr_drug_barcode": "TCGA-73-7498-D32543",
    "bcr_drug_uuid": "554C1877-3CCE-449E-9CA4-5FF8E51826CE",
    "form_completion_date": "2012-5-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad74c0e8-8878-4efc-997d-981cd547bc5b",
    "patient_ID": "TCGA.73.7498",
    "bcr_drug_barcode": "TCGA-73-7498-D48756",
    "bcr_drug_uuid": "5FD1CDCF-3998-4DC4-A725-FE3A445BE552",
    "form_completion_date": "2013-9-20",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad74c0e8-8878-4efc-997d-981cd547bc5b",
    "patient_ID": "TCGA.73.7498",
    "bcr_drug_barcode": "TCGA-73-7498-D48757",
    "bcr_drug_uuid": "C2185383-54C4-42AD-B2BF-402648CCF841",
    "form_completion_date": "2013-9-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60824",
    "bcr_drug_uuid": "F9D3AD0B-B57B-4BC4-BE99-581990D65A30",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60826",
    "bcr_drug_uuid": "0462262C-D185-4D68-B111-FE7D35239FFC",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60827",
    "bcr_drug_uuid": "F252506A-D42C-4B51-8A33-83867E2282B5",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60828",
    "bcr_drug_uuid": "91902CAB-804C-475D-855B-44440709C0BE",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60829",
    "bcr_drug_uuid": "F29AAA5F-2DEF-42E3-AAB4-39BC2259681E",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 242,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 284,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A394996-809F-459F-A647-D209921CCBD2",
    "patient_ID": "TCGA.73.A9RS",
    "bcr_drug_barcode": "TCGA-73-A9RS-D60830",
    "bcr_drug_uuid": "BC782E72-1B7C-451F-A7DD-FF17F0EA035A",
    "form_completion_date": "2014-6-17",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 284,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8d6694c-a213-4544-ac0b-63bce16d8f4e",
    "patient_ID": "TCGA.75.6203",
    "bcr_drug_barcode": "TCGA-75-6203-D15865",
    "bcr_drug_uuid": "a50cc582-dab3-4a3c-b8e7-b5cf188baf9a",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 2
  },
  {
    "bcr_patient_uuid": "a8d6694c-a213-4544-ac0b-63bce16d8f4e",
    "patient_ID": "TCGA.75.6203",
    "bcr_drug_barcode": "TCGA-75-6203-D15863",
    "bcr_drug_uuid": "ebfe876c-5580-4fbe-9edb-8749e6f6a5bd",
    "form_completion_date": "2011-8-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a8d6694c-a213-4544-ac0b-63bce16d8f4e",
    "patient_ID": "TCGA.75.6203",
    "bcr_drug_barcode": "TCGA-75-6203-D15864",
    "bcr_drug_uuid": "51cbf34c-bb80-4826-8d78-451bc17e2701",
    "form_completion_date": "2011-8-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "23069f19-eba5-4ea5-ae7d-1ee4399ce7c1",
    "patient_ID": "TCGA.75.6212",
    "bcr_drug_barcode": "TCGA-75-6212-D15103",
    "bcr_drug_uuid": "29ddd4fa-0d94-4bd7-9ce4-ba2c453d721d",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "23069f19-eba5-4ea5-ae7d-1ee4399ce7c1",
    "patient_ID": "TCGA.75.6212",
    "bcr_drug_barcode": "TCGA-75-6212-D15104",
    "bcr_drug_uuid": "ae10c460-9eda-43b3-a9de-ffc66804c8ba",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 42,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 572
  },
  {
    "bcr_patient_uuid": "23069f19-eba5-4ea5-ae7d-1ee4399ce7c1",
    "patient_ID": "TCGA.75.6212",
    "bcr_drug_barcode": "TCGA-75-6212-D15105",
    "bcr_drug_uuid": "6ea72d6c-a27f-4f01-ba06-912e368af3ea",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 437,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 437
  },
  {
    "bcr_patient_uuid": "df576520-a6b6-4c9b-8d06-3f59cc5342fd",
    "patient_ID": "TCGA.75.7030",
    "bcr_drug_barcode": "TCGA-75-7030-D18797",
    "bcr_drug_uuid": "e83f6d9d-f80b-46df-948c-10ad8c4706a2",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 46,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 552
  },
  {
    "bcr_patient_uuid": "df576520-a6b6-4c9b-8d06-3f59cc5342fd",
    "patient_ID": "TCGA.75.7030",
    "bcr_drug_barcode": "TCGA-75-7030-D18798",
    "bcr_drug_uuid": "0c13d354-be1b-4d41-a8d4-1579f902bf38",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 92,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 736
  },
  {
    "bcr_patient_uuid": "4ef872e1-82c9-4939-9248-41ed9d3085b2",
    "patient_ID": "TCGA.78.7145",
    "bcr_drug_barcode": "TCGA-78-7145-D16675",
    "bcr_drug_uuid": "93f81bc9-f22b-4e9f-85b9-da28d41a7569",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 716,
    "pharmaceutical_tx_ongoing_indicator": false,
    "pharma_type_other": "PHASE II CLINICAL TRIAL KRW2170",
    "regimen_number": 4,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ef872e1-82c9-4939-9248-41ed9d3085b2",
    "patient_ID": "TCGA.78.7145",
    "bcr_drug_barcode": "TCGA-78-7145-D16673",
    "bcr_drug_uuid": "12b1de25-cb72-4778-a205-ad6d7f68c4e4",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 440,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 547,
    "drug_cycles": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ef872e1-82c9-4939-9248-41ed9d3085b2",
    "patient_ID": "TCGA.78.7145",
    "bcr_drug_barcode": "TCGA-78-7145-D16674",
    "bcr_drug_uuid": "8798a8c5-378c-44b9-b21b-f09302daab77",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "GEFITINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 605,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 685,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ef872e1-82c9-4939-9248-41ed9d3085b2",
    "patient_ID": "TCGA.78.7145",
    "bcr_drug_barcode": "TCGA-78-7145-D16672",
    "bcr_drug_uuid": "b3966e3e-c4e0-4a0f-875b-5a2b599ef98d",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4ef872e1-82c9-4939-9248-41ed9d3085b2",
    "patient_ID": "TCGA.78.7145",
    "bcr_drug_barcode": "TCGA-78-7145-D17203",
    "bcr_drug_uuid": "703cc226-f1a6-4c2e-bdc6-dcf30f5b8c11",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc",
    "patient_ID": "TCGA.78.7150",
    "bcr_drug_barcode": "TCGA-78-7150-D16965",
    "bcr_drug_uuid": "071743ff-ba4b-4208-8816-a453c02c436e",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 397,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 615,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 2475
  },
  {
    "bcr_patient_uuid": "a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc",
    "patient_ID": "TCGA.78.7150",
    "bcr_drug_barcode": "TCGA-78-7150-D16966",
    "bcr_drug_uuid": "a4b1e4fb-299c-4c6f-9057-96dc3d724a7c",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 397,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 1800,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 14180
  },
  {
    "bcr_patient_uuid": "a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc",
    "patient_ID": "TCGA.78.7150",
    "bcr_drug_barcode": "TCGA-78-7150-D16967",
    "bcr_drug_uuid": "c90077f8-6d30-4eaa-b791-2d8a389fdfbd",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 140,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "fc79086c-af9a-4c27-b074-f7050b6f3381",
    "patient_ID": "TCGA.78.7155",
    "bcr_drug_barcode": "TCGA-78-7155-D16959",
    "bcr_drug_uuid": "b699c307-543d-4e31-9adf-19275a9cb2ff",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEW PRIMARY"
  },
  {
    "bcr_patient_uuid": "fc79086c-af9a-4c27-b074-f7050b6f3381",
    "patient_ID": "TCGA.78.7155",
    "bcr_drug_barcode": "TCGA-78-7155-D17202",
    "bcr_drug_uuid": "6db2eeea-88ce-495f-b14b-214400fff219",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEW PRIMARY"
  },
  {
    "bcr_patient_uuid": "501c987e-d1eb-48a9-89eb-72a5062c90b4",
    "patient_ID": "TCGA.78.7158",
    "bcr_drug_barcode": "TCGA-78-7158-D16167",
    "bcr_drug_uuid": "b9fc15d3-ee12-436e-8bd1-d57382720f61",
    "form_completion_date": "2011-9-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1220
  },
  {
    "bcr_patient_uuid": "501c987e-d1eb-48a9-89eb-72a5062c90b4",
    "patient_ID": "TCGA.78.7158",
    "bcr_drug_barcode": "TCGA-78-7158-D16978",
    "bcr_drug_uuid": "b2454d2f-cb59-470a-b300-029134f6bb34",
    "form_completion_date": "2011-9-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 620
  },
  {
    "bcr_patient_uuid": "c1a01e8c-1f7e-4e24-bfad-90b73f88e992",
    "patient_ID": "TCGA.78.7160",
    "bcr_drug_barcode": "TCGA-78-7160-D17521",
    "bcr_drug_uuid": "dfe0d27b-fd72-4141-82d3-f56f096e7434",
    "form_completion_date": "2011-10-14",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "86faf16c-56fd-4b7b-a6b2-b4c83bec93e1",
    "patient_ID": "TCGA.78.7161",
    "bcr_drug_barcode": "TCGA-78-7161-D18781",
    "bcr_drug_uuid": "d8438615-27ba-430d-b895-ba73933869c4",
    "form_completion_date": "2011-11-25",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "86faf16c-56fd-4b7b-a6b2-b4c83bec93e1",
    "patient_ID": "TCGA.78.7161",
    "bcr_drug_barcode": "TCGA-78-7161-D18780",
    "bcr_drug_uuid": "0303cacf-83d5-48d3-970a-5ba7b72c1bc6",
    "form_completion_date": "2011-11-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "46592b7b-6968-42a6-83af-0917c9f4a9a5",
    "patient_ID": "TCGA.78.7535",
    "bcr_drug_barcode": "TCGA-78-7535-D20640",
    "bcr_drug_uuid": "b445a5a2-5b5c-47d3-962d-04da28489e68",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "46592b7b-6968-42a6-83af-0917c9f4a9a5",
    "patient_ID": "TCGA.78.7535",
    "bcr_drug_barcode": "TCGA-78-7535-D20641",
    "bcr_drug_uuid": "81a1889c-bbcb-408b-8c95-1a0acf920311",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 56
  },
  {
    "bcr_patient_uuid": "7be86a90-6da8-4c01-8a7a-bc5cfef9894f",
    "patient_ID": "TCGA.78.7539",
    "bcr_drug_barcode": "TCGA-78-7539-D20645",
    "bcr_drug_uuid": "55910d2b-0159-402a-a7c3-dc40c6dd4fcd",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 37.5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 112.5
  },
  {
    "bcr_patient_uuid": "7be86a90-6da8-4c01-8a7a-bc5cfef9894f",
    "patient_ID": "TCGA.78.7539",
    "bcr_drug_barcode": "TCGA-78-7539-D20646",
    "bcr_drug_uuid": "0a178b02-54e3-4690-8a6b-a18c85384aa2",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 284,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1167
  },
  {
    "bcr_patient_uuid": "7be86a90-6da8-4c01-8a7a-bc5cfef9894f",
    "patient_ID": "TCGA.78.7539",
    "bcr_drug_barcode": "TCGA-78-7539-D20644",
    "bcr_drug_uuid": "ee4766b1-b93f-47b2-8296-193336607673",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "7be86a90-6da8-4c01-8a7a-bc5cfef9894f",
    "patient_ID": "TCGA.78.7539",
    "bcr_drug_barcode": "TCGA-78-7539-D20647",
    "bcr_drug_uuid": "ef32890a-c5fc-4abf-915c-3c0394c365a4",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 262,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1048
  },
  {
    "bcr_patient_uuid": "dcd066ba-5894-453e-b1da-82092858c3db",
    "patient_ID": "TCGA.86.6562",
    "bcr_drug_barcode": "TCGA-86-6562-D29769",
    "bcr_drug_uuid": "f359ca59-3a44-488c-bfc2-7aea795f3d57",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "dcd066ba-5894-453e-b1da-82092858c3db",
    "patient_ID": "TCGA.86.6562",
    "bcr_drug_barcode": "TCGA-86-6562-D29767",
    "bcr_drug_uuid": "02372dd0-f7cc-47c8-a3d0-0c6031d75cda",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D36483",
    "bcr_drug_uuid": "EC1417C7-2349-4F98-939F-E7E643F30F87",
    "form_completion_date": "2012-10-31",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D36484",
    "bcr_drug_uuid": "24A17B71-0E0B-4803-A21C-02BCB336024D",
    "form_completion_date": "2012-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58402",
    "bcr_drug_uuid": "08D438DF-4B04-42CE-92EB-6AAC1EF6952E",
    "form_completion_date": "2014-4-9",
    "clinical_trial_drug_classification": "TYROSINE KINASE INHIBITOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58403",
    "bcr_drug_uuid": "7741F434-FD67-473C-B872-5A2B21734ED8",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58404",
    "bcr_drug_uuid": "444CAEFF-EDEE-460D-9C88-C49C232A90DB",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58405",
    "bcr_drug_uuid": "D7831CC1-B080-4F51-A2C1-3A32B60AA83F",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58407",
    "bcr_drug_uuid": "8C75D7CE-9FC9-4BFF-B261-DD159CFED86F",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 936,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde",
    "patient_ID": "TCGA.86.7701",
    "bcr_drug_barcode": "TCGA-86-7701-D58408",
    "bcr_drug_uuid": "DC37E270-9E05-421E-A7F4-8B20DF86DC92",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 936,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9c894668-88f5-4308-a1c0-6b8acc6aaaec",
    "patient_ID": "TCGA.86.7711",
    "bcr_drug_barcode": "TCGA-86-7711-D36470",
    "bcr_drug_uuid": "5969CF61-8D1A-4E11-8018-EA0CC6004B7B",
    "form_completion_date": "2012-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9c894668-88f5-4308-a1c0-6b8acc6aaaec",
    "patient_ID": "TCGA.86.7711",
    "bcr_drug_barcode": "TCGA-86-7711-D36471",
    "bcr_drug_uuid": "88D02F6F-8FB9-47F9-8722-B3078EA28D7B",
    "form_completion_date": "2012-10-31",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc68632c-b1e3-491b-b562-9468e2d1c101",
    "patient_ID": "TCGA.86.7713",
    "bcr_drug_barcode": "TCGA-86-7713-D35429",
    "bcr_drug_uuid": "505DA070-940F-431E-B3D0-0DEC1E27D175",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc68632c-b1e3-491b-b562-9468e2d1c101",
    "patient_ID": "TCGA.86.7713",
    "bcr_drug_barcode": "TCGA-86-7713-D35430",
    "bcr_drug_uuid": "20185B1B-9AFC-48FB-A72A-4E830C7CB786",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "079ae0b3-b64b-4b8e-ab7d-225b8046568c",
    "patient_ID": "TCGA.86.7954",
    "bcr_drug_barcode": "TCGA-86-7954-D57949",
    "bcr_drug_uuid": "D1519FCC-3805-4E15-B46C-49EA3BCEEC7D",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "079ae0b3-b64b-4b8e-ab7d-225b8046568c",
    "patient_ID": "TCGA.86.7954",
    "bcr_drug_barcode": "TCGA-86-7954-D57950",
    "bcr_drug_uuid": "3D5B9CB0-F3CF-411C-8AFB-E3271BA29B8C",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0d0d83d9-d558-4d38-977b-6f1b2471beda",
    "patient_ID": "TCGA.86.7955",
    "bcr_drug_barcode": "TCGA-86-7955-D41098",
    "bcr_drug_uuid": "7C0A1FDD-293F-4DF9-AC3D-67AB0630FF20",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "VEPESID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0d0d83d9-d558-4d38-977b-6f1b2471beda",
    "patient_ID": "TCGA.86.7955",
    "bcr_drug_barcode": "TCGA-86-7955-D41099",
    "bcr_drug_uuid": "6E123B02-3E4D-4660-9400-A5BDA061292D",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0d0d83d9-d558-4d38-977b-6f1b2471beda",
    "patient_ID": "TCGA.86.7955",
    "bcr_drug_barcode": "TCGA-86-7955-D63518",
    "bcr_drug_uuid": "B33DF174-A60F-4916-97D6-315FF1B3CBF3",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 823,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 922,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0d0d83d9-d558-4d38-977b-6f1b2471beda",
    "patient_ID": "TCGA.86.7955",
    "bcr_drug_barcode": "TCGA-86-7955-D63519",
    "bcr_drug_uuid": "4F1FAE32-57AF-472B-8BCD-8E1EAB496CDC",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 823,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 922,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0fe909ea-d52c-4b71-816f-57f62d4a5744",
    "patient_ID": "TCGA.86.8054",
    "bcr_drug_barcode": "TCGA-86-8054-D41093",
    "bcr_drug_uuid": "AB80A551-9E5E-4095-8852-00599B1C8859",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0fe909ea-d52c-4b71-816f-57f62d4a5744",
    "patient_ID": "TCGA.86.8054",
    "bcr_drug_barcode": "TCGA-86-8054-D41094",
    "bcr_drug_uuid": "7BBDF359-8AE5-4BBC-9539-38B87210A586",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8869000d-09d7-465a-ac32-54d1935c43e7",
    "patient_ID": "TCGA.86.8075",
    "bcr_drug_barcode": "TCGA-86-8075-D41680",
    "bcr_drug_uuid": "3C971D88-EA87-4F2F-893C-B7BB558C402E",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 201,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 364,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8869000d-09d7-465a-ac32-54d1935c43e7",
    "patient_ID": "TCGA.86.8075",
    "bcr_drug_barcode": "TCGA-86-8075-D41681",
    "bcr_drug_uuid": "7E6A245F-8FC9-4F05-BA87-C6FC12A202EB",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 201,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 364,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8869000d-09d7-465a-ac32-54d1935c43e7",
    "patient_ID": "TCGA.86.8075",
    "bcr_drug_barcode": "TCGA-86-8075-D41682",
    "bcr_drug_uuid": "9C62E82D-EABF-452D-9CE1-6F3146D45E6C",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "GEFITINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 388,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8609edfc-119d-4d63-9188-c86aabd5ca52",
    "patient_ID": "TCGA.86.8076",
    "bcr_drug_barcode": "TCGA-86-8076-D41684",
    "bcr_drug_uuid": "50F44FAB-0ED8-4107-BFA7-F1D90752FECF",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8609edfc-119d-4d63-9188-c86aabd5ca52",
    "patient_ID": "TCGA.86.8076",
    "bcr_drug_barcode": "TCGA-86-8076-D41685",
    "bcr_drug_uuid": "6DF79C11-EF79-4AF7-90DA-26FB54BB5161",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a816e355-be6f-4d16-b051-b6d86ed8cded",
    "patient_ID": "TCGA.86.8278",
    "bcr_drug_barcode": "TCGA-86-8278-D41670",
    "bcr_drug_uuid": "964E5BFB-3A3B-47C8-A346-6F5BDACA4D99",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a816e355-be6f-4d16-b051-b6d86ed8cded",
    "patient_ID": "TCGA.86.8278",
    "bcr_drug_barcode": "TCGA-86-8278-D41671",
    "bcr_drug_uuid": "9ACDE909-44BF-475C-AAFC-8C721F24CFD9",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a816e355-be6f-4d16-b051-b6d86ed8cded",
    "patient_ID": "TCGA.86.8278",
    "bcr_drug_barcode": "TCGA-86-8278-D41672",
    "bcr_drug_uuid": "8C3C7ABD-D1E8-4672-965B-91AF4B8F03CE",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "GEFITINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 178,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2923e404-38f2-437a-b57e-23401fbe0273",
    "patient_ID": "TCGA.86.8279",
    "bcr_drug_barcode": "TCGA-86-8279-D41676",
    "bcr_drug_uuid": "9F2065E1-C62F-4D2A-92CB-B1DB2F7963E2",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2923e404-38f2-437a-b57e-23401fbe0273",
    "patient_ID": "TCGA.86.8279",
    "bcr_drug_barcode": "TCGA-86-8279-D41677",
    "bcr_drug_uuid": "233E4E3A-65B3-467B-B214-C52773DD2094",
    "form_completion_date": "2013-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8faa3a7-6b3f-4e69-8c88-184e41055bd7",
    "patient_ID": "TCGA.86.8280",
    "bcr_drug_barcode": "TCGA-86-8280-D66080",
    "bcr_drug_uuid": "7B11F24A-04FA-472B-A420-D8E1764C3600",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8faa3a7-6b3f-4e69-8c88-184e41055bd7",
    "patient_ID": "TCGA.86.8280",
    "bcr_drug_barcode": "TCGA-86-8280-D66081",
    "bcr_drug_uuid": "2895FB6B-3FC1-4DFD-B743-1CB915268336",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b89166e-c5b8-481b-aa70-495141499b91",
    "patient_ID": "TCGA.86.8669",
    "bcr_drug_barcode": "TCGA-86-8669-D66086",
    "bcr_drug_uuid": "E18E7469-7056-41A2-8BB1-43EE190292AC",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 854,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 938,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b89166e-c5b8-481b-aa70-495141499b91",
    "patient_ID": "TCGA.86.8669",
    "bcr_drug_barcode": "TCGA-86-8669-D66087",
    "bcr_drug_uuid": "336C3649-8213-4895-8F57-85A6FEE79492",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 854,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 938,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c4cfa3cc-e305-42dd-be57-97efbb891659",
    "patient_ID": "TCGA.86.8671",
    "bcr_drug_barcode": "TCGA-86-8671-D66090",
    "bcr_drug_uuid": "151A219B-0DB6-4158-A30B-35B97CC9A1A9",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c4cfa3cc-e305-42dd-be57-97efbb891659",
    "patient_ID": "TCGA.86.8671",
    "bcr_drug_barcode": "TCGA-86-8671-D66091",
    "bcr_drug_uuid": "36EB3446-D9DC-4620-830A-8CE6A214F2DB",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a1eea76-e19a-4547-9b24-abf7051cc4db",
    "patient_ID": "TCGA.86.8674",
    "bcr_drug_barcode": "TCGA-86-8674-D42028",
    "bcr_drug_uuid": "55CE92CA-ED7F-460F-BCDD-25F915DE1A54",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a1eea76-e19a-4547-9b24-abf7051cc4db",
    "patient_ID": "TCGA.86.8674",
    "bcr_drug_barcode": "TCGA-86-8674-D42029",
    "bcr_drug_uuid": "34F415AA-90DB-4E2C-9F08-160D35EAA160",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "528A0FCE-0719-4B19-A69D-3F18681696C5",
    "patient_ID": "TCGA.86.A4D0",
    "bcr_drug_barcode": "TCGA-86-A4D0-D52966",
    "bcr_drug_uuid": "6BF8E543-7F35-4B18-83AE-963B50ADA0CD",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "528A0FCE-0719-4B19-A69D-3F18681696C5",
    "patient_ID": "TCGA.86.A4D0",
    "bcr_drug_barcode": "TCGA-86-A4D0-D52968",
    "bcr_drug_uuid": "781B2224-221B-4BDA-9872-513C7BF06A99",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E01E4FB3-236A-4D16-9073-555876B688E9",
    "patient_ID": "TCGA.86.A4JF",
    "bcr_drug_barcode": "TCGA-86-A4JF-D52793",
    "bcr_drug_uuid": "85E463A3-A1DE-4C8E-8C0F-9BD9AB0377D8",
    "form_completion_date": "2013-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E01E4FB3-236A-4D16-9073-555876B688E9",
    "patient_ID": "TCGA.86.A4JF",
    "bcr_drug_barcode": "TCGA-86-A4JF-D52796",
    "bcr_drug_uuid": "F06AAA11-F3BF-4A51-BA60-963FDE4D8CB8",
    "form_completion_date": "2013-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 536,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "646910EE-5F5D-40AC-A21A-75790F89430A",
    "patient_ID": "TCGA.86.A4P8",
    "bcr_drug_barcode": "TCGA-86-A4P8-D48293",
    "bcr_drug_uuid": "C22B8623-E5C2-4F22-8CCD-7859A4802584",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "646910EE-5F5D-40AC-A21A-75790F89430A",
    "patient_ID": "TCGA.86.A4P8",
    "bcr_drug_barcode": "TCGA-86-A4P8-D48295",
    "bcr_drug_uuid": "054E5CD2-940A-4364-A458-39387314D2AE",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0232d299-4cdf-4fd7-9a5e-8d13c208b40c",
    "patient_ID": "TCGA.91.6848",
    "bcr_drug_barcode": "TCGA-91-6848-D32644",
    "bcr_drug_uuid": "84DFEC23-536C-4115-8F5A-A423FC91FAE2",
    "form_completion_date": "2012-6-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "0232d299-4cdf-4fd7-9a5e-8d13c208b40c",
    "patient_ID": "TCGA.91.6848",
    "bcr_drug_barcode": "TCGA-91-6848-D33330",
    "bcr_drug_uuid": "C0CD8924-B559-41B3-B3A3-53EFB06231E5",
    "form_completion_date": "2012-6-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "c0fdb152-25d2-404b-bec7-a43ece381f5b",
    "patient_ID": "TCGA.91.7771",
    "bcr_drug_barcode": "TCGA-91-7771-D37917",
    "bcr_drug_uuid": "494CE129-C26D-4374-B915-382105753D85",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "c0fdb152-25d2-404b-bec7-a43ece381f5b",
    "patient_ID": "TCGA.91.7771",
    "bcr_drug_barcode": "TCGA-91-7771-D37919",
    "bcr_drug_uuid": "7D947262-1775-4C0C-981A-AAF1E6E7D92E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "9DDA72EC-1698-44E2-B35C-11E9A2704380",
    "patient_ID": "TCGA.93.A4JN",
    "bcr_drug_barcode": "TCGA-93-A4JN-D64292",
    "bcr_drug_uuid": "45BA034F-50ED-4FD8-ADE2-AE234CC3F945",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "BELINOSTAT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9DDA72EC-1698-44E2-B35C-11E9A2704380",
    "patient_ID": "TCGA.93.A4JN",
    "bcr_drug_barcode": "TCGA-93-A4JN-D64293",
    "bcr_drug_uuid": "7A4ADFCB-3BF9-433A-8A71-9BF156B3E93A",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 410,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 697,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "30F276A8-3A4B-4DE8-AEA0-7F605D100401",
    "patient_ID": "TCGA.93.A4JP",
    "bcr_drug_barcode": "TCGA-93-A4JP-D65104",
    "bcr_drug_uuid": "6D848A43-59A3-46FE-9574-9F37B0059EC8",
    "form_completion_date": "2014-9-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "193201a3-1447-47b1-bdf1-11ae0eb3b2f3",
    "patient_ID": "TCGA.95.7562",
    "bcr_drug_barcode": "TCGA-95-7562-D33261",
    "bcr_drug_uuid": "1CB62B54-E04A-4A35-A0C0-5362A3F24D93",
    "form_completion_date": "2012-6-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "193201a3-1447-47b1-bdf1-11ae0eb3b2f3",
    "patient_ID": "TCGA.95.7562",
    "bcr_drug_barcode": "TCGA-95-7562-D33262",
    "bcr_drug_uuid": "4F33410C-01F5-4F0E-A0A8-A416520BE0F7",
    "form_completion_date": "2012-6-26",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3bc7026f-73f2-418b-bd62-f4768582b790",
    "patient_ID": "TCGA.95.7567",
    "bcr_drug_barcode": "TCGA-95-7567-D21124",
    "bcr_drug_uuid": "277b806f-ce51-4dee-b155-04b7617289b8",
    "form_completion_date": "2012-1-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 620
  },
  {
    "bcr_patient_uuid": "3bc7026f-73f2-418b-bd62-f4768582b790",
    "patient_ID": "TCGA.95.7567",
    "bcr_drug_barcode": "TCGA-95-7567-D21202",
    "bcr_drug_uuid": "524d0bef-d243-4ebc-9d01-e82ca5387c26",
    "form_completion_date": "2012-2-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 620
  },
  {
    "bcr_patient_uuid": "D344DAE0-ADF4-4697-B703-7690C13D8331",
    "patient_ID": "TCGA.95.A4VK",
    "bcr_drug_barcode": "TCGA-95-A4VK-D40500",
    "bcr_drug_uuid": "676EB575-B085-4F0A-AAD2-CD3F2A17544E",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D344DAE0-ADF4-4697-B703-7690C13D8331",
    "patient_ID": "TCGA.95.A4VK",
    "bcr_drug_barcode": "TCGA-95-A4VK-D40512",
    "bcr_drug_uuid": "F28DCD0F-6819-45FB-9F86-5FACA3E69090",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E22A3AF-7F28-4757-8684-ED64A2A27AD1",
    "patient_ID": "TCGA.95.A4VP",
    "bcr_drug_barcode": "TCGA-95-A4VP-D40540",
    "bcr_drug_uuid": "EEC4E284-83E6-48D8-9E22-87A68963B598",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E22A3AF-7F28-4757-8684-ED64A2A27AD1",
    "patient_ID": "TCGA.95.A4VP",
    "bcr_drug_barcode": "TCGA-95-A4VP-D40543",
    "bcr_drug_uuid": "B3A1D470-D0D9-4ABF-A3AF-1447CD0096B4",
    "form_completion_date": "2013-2-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1d90c9f3-5025-4867-a2f0-e455b6a254fa",
    "patient_ID": "TCGA.97.7546",
    "bcr_drug_barcode": "TCGA-97-7546-D32027",
    "bcr_drug_uuid": "BFAB42A6-E8C6-4F2C-AAE1-8C7D88AB5CFD",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6092bd5c-e97c-4a77-a4ad-c87623b17507",
    "patient_ID": "TCGA.97.7547",
    "bcr_drug_barcode": "TCGA-97-7547-D19225",
    "bcr_drug_uuid": "6da633dd-18f1-40bd-a370-cdbee368a8b2",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "6092bd5c-e97c-4a77-a4ad-c87623b17507",
    "patient_ID": "TCGA.97.7547",
    "bcr_drug_barcode": "TCGA-97-7547-D19222",
    "bcr_drug_uuid": "01e4dd25-611e-44b1-a8fa-6907e2e5f41c",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "6092bd5c-e97c-4a77-a4ad-c87623b17507",
    "patient_ID": "TCGA.97.7547",
    "bcr_drug_barcode": "TCGA-97-7547-D19232",
    "bcr_drug_uuid": "1744a5f8-ceb6-4df7-9801-ffe6d2e7dfc0",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 824,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 866,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 788,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3152
  },
  {
    "bcr_patient_uuid": "6092bd5c-e97c-4a77-a4ad-c87623b17507",
    "patient_ID": "TCGA.97.7547",
    "bcr_drug_barcode": "TCGA-97-7547-D19221",
    "bcr_drug_uuid": "1dee112c-3291-47a9-b009-eb9c1d669e75",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 39,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 39
  },
  {
    "bcr_patient_uuid": "6092bd5c-e97c-4a77-a4ad-c87623b17507",
    "patient_ID": "TCGA.97.7547",
    "bcr_drug_barcode": "TCGA-97-7547-D19224",
    "bcr_drug_uuid": "d1fd8e0b-6c15-4718-a3f0-e4c15eba9dfa",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "a9644274-13bb-4228-9b4f-14260ccc26eb",
    "patient_ID": "TCGA.97.7554",
    "bcr_drug_barcode": "TCGA-97-7554-D18639",
    "bcr_drug_uuid": "779af18b-5c23-4e62-ae9c-b6288f15b3da",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 817,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3268
  },
  {
    "bcr_patient_uuid": "a9644274-13bb-4228-9b4f-14260ccc26eb",
    "patient_ID": "TCGA.97.7554",
    "bcr_drug_barcode": "TCGA-97-7554-D18627",
    "bcr_drug_uuid": "c7851da9-c4f2-4a19-b48c-a90e5b4d9cba",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "397d3f69-1453-4057-b177-8723eec923d1",
    "patient_ID": "TCGA.97.8171",
    "bcr_drug_barcode": "TCGA-97-8171-D44343",
    "bcr_drug_uuid": "26978718-D8A3-4747-A8BE-D3C96E87A6A3",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c695c24-e7f9-449a-9258-a1bc8a33bf9a",
    "patient_ID": "TCGA.97.8174",
    "bcr_drug_barcode": "TCGA-97-8174-D32911",
    "bcr_drug_uuid": "78B19468-4913-4164-B4EF-AF0FD08CB063",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c695c24-e7f9-449a-9258-a1bc8a33bf9a",
    "patient_ID": "TCGA.97.8174",
    "bcr_drug_barcode": "TCGA-97-8174-D32912",
    "bcr_drug_uuid": "093ACF14-8C3A-40FC-9089-FB1AE39C6278",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f4350d9c-3f40-4829-bbc4-8acb2f3ff512",
    "patient_ID": "TCGA.97.8175",
    "bcr_drug_barcode": "TCGA-97-8175-D44236",
    "bcr_drug_uuid": "9EF4D129-7435-454B-B14A-430A7F80A624",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 472,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f4350d9c-3f40-4829-bbc4-8acb2f3ff512",
    "patient_ID": "TCGA.97.8175",
    "bcr_drug_barcode": "TCGA-97-8175-D44238",
    "bcr_drug_uuid": "8165798D-0A35-4166-92DD-22748F0BB7A0",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 472,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12c27db5-db2f-48dc-a2ca-9557b951f43e",
    "patient_ID": "TCGA.97.8176",
    "bcr_drug_barcode": "TCGA-97-8176-D35660",
    "bcr_drug_uuid": "3CDB750D-9A1C-4C74-B647-D988440014AE",
    "form_completion_date": "2012-10-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12c27db5-db2f-48dc-a2ca-9557b951f43e",
    "patient_ID": "TCGA.97.8176",
    "bcr_drug_barcode": "TCGA-97-8176-D35661",
    "bcr_drug_uuid": "C2AF0586-F52E-443A-9120-934B54628579",
    "form_completion_date": "2012-10-5",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12c27db5-db2f-48dc-a2ca-9557b951f43e",
    "patient_ID": "TCGA.97.8176",
    "bcr_drug_barcode": "TCGA-97-8176-D35662",
    "bcr_drug_uuid": "49597D40-3617-493C-8061-8DCCB9871B6B",
    "form_completion_date": "2012-10-5",
    "pharmaceutical_therapy_drug_name": "B12",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12c27db5-db2f-48dc-a2ca-9557b951f43e",
    "patient_ID": "TCGA.97.8176",
    "bcr_drug_barcode": "TCGA-97-8176-D49551",
    "bcr_drug_uuid": "51434296-C639-41F5-82B1-E61B82E05160",
    "form_completion_date": "2013-10-3",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12c27db5-db2f-48dc-a2ca-9557b951f43e",
    "patient_ID": "TCGA.97.8176",
    "bcr_drug_barcode": "TCGA-97-8176-D49550",
    "bcr_drug_uuid": "6B643397-9B35-4517-A6EC-013C81A73723",
    "form_completion_date": "2013-10-3",
    "pharmaceutical_therapy_drug_name": "XGEVA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09078761-1c14-4d01-8e15-535c19a9b0f9",
    "patient_ID": "TCGA.97.8177",
    "bcr_drug_barcode": "TCGA-97-8177-D32866",
    "bcr_drug_uuid": "E1EB8A22-561A-4E54-9A4A-AE4C3AB3056A",
    "form_completion_date": "2012-6-14",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09078761-1c14-4d01-8e15-535c19a9b0f9",
    "patient_ID": "TCGA.97.8177",
    "bcr_drug_barcode": "TCGA-97-8177-D32868",
    "bcr_drug_uuid": "AA1A57A5-C0DC-4888-A6D2-E6C632A31929",
    "form_completion_date": "2012-6-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09078761-1c14-4d01-8e15-535c19a9b0f9",
    "patient_ID": "TCGA.97.8177",
    "bcr_drug_barcode": "TCGA-97-8177-D44245",
    "bcr_drug_uuid": "46424E43-2394-4493-8F96-9A71AF33D4F8",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ac0d7a82-82cb-4aec-b859-e37375f3de8b",
    "patient_ID": "TCGA.97.8547",
    "bcr_drug_barcode": "TCGA-97-8547-D35445",
    "bcr_drug_uuid": "46926057-7C1B-4651-913D-B4C08C699594",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ac0d7a82-82cb-4aec-b859-e37375f3de8b",
    "patient_ID": "TCGA.97.8547",
    "bcr_drug_barcode": "TCGA-97-8547-D35446",
    "bcr_drug_uuid": "8EDFE56A-3EB6-47A8-A4BA-2255FF3A3418",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ac0d7a82-82cb-4aec-b859-e37375f3de8b",
    "patient_ID": "TCGA.97.8547",
    "bcr_drug_barcode": "TCGA-97-8547-D35447",
    "bcr_drug_uuid": "393D56D3-0031-4F0A-9E38-F16B66B602D5",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96d93e23-bb0d-46a8-9685-5ed0d6b83059",
    "patient_ID": "TCGA.99.7458",
    "bcr_drug_barcode": "TCGA-99-7458-D20337",
    "bcr_drug_uuid": "c261c20d-0ded-4038-a815-f22775bf86a6",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "TARCEVA (ERLOTINIB)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_units": "MG/DAY",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "84c3ba70-afa7-4b69-be69-7ec8d6022c56",
    "patient_ID": "TCGA.99.8025",
    "bcr_drug_barcode": "TCGA-99-8025-D33590",
    "bcr_drug_uuid": "E437156A-F538-4BCB-9CC6-2B6DC295AA6D",
    "form_completion_date": "2012-7-9",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 286,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9582b436-145b-4f84-8f7f-8b39b8254cc1",
    "patient_ID": "TCGA.99.8033",
    "bcr_drug_barcode": "TCGA-99-8033-D32956",
    "bcr_drug_uuid": "AAAFB521-2D55-4F3A-A369-95F7C05964EB",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9582b436-145b-4f84-8f7f-8b39b8254cc1",
    "patient_ID": "TCGA.99.8033",
    "bcr_drug_barcode": "TCGA-99-8033-D32958",
    "bcr_drug_uuid": "05A9596F-9551-49BF-8D1F-F899C9375EFC",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9582b436-145b-4f84-8f7f-8b39b8254cc1",
    "patient_ID": "TCGA.99.8033",
    "bcr_drug_barcode": "TCGA-99-8033-D32959",
    "bcr_drug_uuid": "987496D9-FF47-4ADB-B105-C8AF22F185E4",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "369f14c4-2191-4962-a309-3e23ddc4e5fc",
    "patient_ID": "TCGA.J2.8192",
    "bcr_drug_barcode": "TCGA-J2-8192-D32572",
    "bcr_drug_uuid": "5FA2C5DE-EEB3-450E-8D40-F0B739F6106D",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "369f14c4-2191-4962-a309-3e23ddc4e5fc",
    "patient_ID": "TCGA.J2.8192",
    "bcr_drug_barcode": "TCGA-J2-8192-D32574",
    "bcr_drug_uuid": "5751CCC2-7B5B-4703-8405-CF1E474220FB",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "369f14c4-2191-4962-a309-3e23ddc4e5fc",
    "patient_ID": "TCGA.J2.8192",
    "bcr_drug_barcode": "TCGA-J2-8192-D55392",
    "bcr_drug_uuid": "A136AC0B-F93F-4B43-AE17-770DADF20159",
    "form_completion_date": "2014-4-16",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 641,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D32562",
    "bcr_drug_uuid": "2FAE07DB-7F3D-45D6-BA62-5C795B46A511",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D32566",
    "bcr_drug_uuid": "04888E00-4D3A-44D4-9C38-BB9DA5B386B7",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D55424",
    "bcr_drug_uuid": "4C297630-A1FD-4811-899D-AA652ACB4F3D",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D55426",
    "bcr_drug_uuid": "726C1CA1-1718-4EA7-9CAC-8701FA927C14",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D55427",
    "bcr_drug_uuid": "7AE778AB-433A-4D39-AB87-A4A38B5EF832",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "DOXETAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 640,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4",
    "patient_ID": "TCGA.J2.8194",
    "bcr_drug_barcode": "TCGA-J2-8194-D55428",
    "bcr_drug_uuid": "F21DD793-5C47-438B-9CBC-8E3B6B4DE464",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 663,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A5F2576A-D628-47DE-A5DF-76A4F3105DCC",
    "patient_ID": "TCGA.L9.A743",
    "bcr_drug_barcode": "TCGA-L9-A743-D58553",
    "bcr_drug_uuid": "88D31EDF-D154-4FAF-B5A3-0BABE6D20D73",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A5F2576A-D628-47DE-A5DF-76A4F3105DCC",
    "patient_ID": "TCGA.L9.A743",
    "bcr_drug_barcode": "TCGA-L9-A743-D58554",
    "bcr_drug_uuid": "BD488F92-7CB9-4C9E-B60D-9F199C561475",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54E90433-5218-4D83-848F-F995ECBA2A63",
    "patient_ID": "TCGA.L9.A7SV",
    "bcr_drug_barcode": "TCGA-L9-A7SV-D55465",
    "bcr_drug_uuid": "01FFB728-9015-4A08-9273-307A5FFCA9C7",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54E90433-5218-4D83-848F-F995ECBA2A63",
    "patient_ID": "TCGA.L9.A7SV",
    "bcr_drug_barcode": "TCGA-L9-A7SV-D55466",
    "bcr_drug_uuid": "AF22DDC1-B76C-49AC-AAC4-32359ACDB718",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "PEMETREXED DISODIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7C4ED533-EE66-48BE-A84B-FF8607742818",
    "patient_ID": "TCGA.MP.A4T8",
    "bcr_drug_barcode": "TCGA-MP-A4T8-D41347",
    "bcr_drug_uuid": "5847897E-0C0F-4333-98FC-46101B12E294",
    "form_completion_date": "2013-3-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7C4ED533-EE66-48BE-A84B-FF8607742818",
    "patient_ID": "TCGA.MP.A4T8",
    "bcr_drug_barcode": "TCGA-MP-A4T8-D41348",
    "bcr_drug_uuid": "254AEB4C-E848-471D-90B6-75DC48A1F902",
    "form_completion_date": "2013-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70081320-540F-41D2-8687-EE6D011F8EB0",
    "patient_ID": "TCGA.MP.A4T9",
    "bcr_drug_barcode": "TCGA-MP-A4T9-D41350",
    "bcr_drug_uuid": "C9F75A26-D387-48A4-BA06-A9D5C58CA315",
    "form_completion_date": "2013-3-15",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 55,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70081320-540F-41D2-8687-EE6D011F8EB0",
    "patient_ID": "TCGA.MP.A4T9",
    "bcr_drug_barcode": "TCGA-MP-A4T9-D41351",
    "bcr_drug_uuid": "758F08E1-B373-4964-9966-691B1D562B6C",
    "form_completion_date": "2013-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 55,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70081320-540F-41D2-8687-EE6D011F8EB0",
    "patient_ID": "TCGA.MP.A4T9",
    "bcr_drug_barcode": "TCGA-MP-A4T9-D41352",
    "bcr_drug_uuid": "ECBC2354-5C73-46FD-94A7-D519D192334F",
    "form_completion_date": "2013-3-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "99C35245-E1C8-4805-B7A5-F703BB506030",
    "patient_ID": "TCGA.MP.A4TC",
    "bcr_drug_barcode": "TCGA-MP-A4TC-D41397",
    "bcr_drug_uuid": "2D936FD6-139F-4EBD-9EAB-D843254E987A",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 25,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "99C35245-E1C8-4805-B7A5-F703BB506030",
    "patient_ID": "TCGA.MP.A4TC",
    "bcr_drug_barcode": "TCGA-MP-A4TC-D41398",
    "bcr_drug_uuid": "ED1C314A-2C4D-4A19-A6A2-0FB17145C3E5",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 25,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "383D1253-349F-43B3-BEBD-9F1D1CF14B3D",
    "patient_ID": "TCGA.MP.A4TD",
    "bcr_drug_barcode": "TCGA-MP-A4TD-D41400",
    "bcr_drug_uuid": "151B0D62-C2EE-442B-8FC7-DDCE9131ABBD",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "383D1253-349F-43B3-BEBD-9F1D1CF14B3D",
    "patient_ID": "TCGA.MP.A4TD",
    "bcr_drug_barcode": "TCGA-MP-A4TD-D41401",
    "bcr_drug_uuid": "429B9434-707A-41B3-A4B6-07DA60A412A3",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86DAC334-F30E-438E-810A-8E45F69DBB7E",
    "patient_ID": "TCGA.MP.A4TF",
    "bcr_drug_barcode": "TCGA-MP-A4TF-D41409",
    "bcr_drug_uuid": "DB475CAC-B2D9-461C-A714-D5BBD7B9CF48",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86DAC334-F30E-438E-810A-8E45F69DBB7E",
    "patient_ID": "TCGA.MP.A4TF",
    "bcr_drug_barcode": "TCGA-MP-A4TF-D41410",
    "bcr_drug_uuid": "51556339-4419-45EF-B7B5-597FECF9A3D5",
    "form_completion_date": "2013-3-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01E9888D-B5B9-48F1-8BA6-8A89AF108A04",
    "patient_ID": "TCGA.NJ.A7XG",
    "bcr_drug_barcode": "TCGA-NJ-A7XG-D71392",
    "bcr_drug_uuid": "722B8970-EEDA-4CD9-B2C5-9FE8E763C119",
    "form_completion_date": "2015-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01E9888D-B5B9-48F1-8BA6-8A89AF108A04",
    "patient_ID": "TCGA.NJ.A7XG",
    "bcr_drug_barcode": "TCGA-NJ-A7XG-D71393",
    "bcr_drug_uuid": "4006A0DF-514F-45D2-8CFA-20E163DF66DE",
    "form_completion_date": "2015-3-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01E9888D-B5B9-48F1-8BA6-8A89AF108A04",
    "patient_ID": "TCGA.NJ.A7XG",
    "bcr_drug_barcode": "TCGA-NJ-A7XG-D71463",
    "bcr_drug_uuid": "3340775B-1C82-4EB8-9F90-84B465A9C799",
    "form_completion_date": "2015-3-25",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
